干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 6808|回复: 2
go

[已解决求助] 求助Development. 2011 Nov;138(21):4801-12.文献 [复制链接]

Rank: 3Rank: 3

积分
318 
威望
318  
包包
7  

优秀会员

楼主
发表于 2011-11-2 22:30 |只看该作者 |倒序浏览 |打印
干细胞之家微信公众号
Development. 2011 Nov;138(21):4801-12.) a& \! ^) U$ Q5 d4 E+ }# V  U# R6 x1 g) x
ER71 directs mesodermal fate decisions during embryogenesis.; h5 x1 k9 a6 Q$ M
Rasmussen TL, Kweon J, Diekmann MA, Belema-Bedada F, Song Q, Bowlin K, Shi X, Ferdous A, Li T, Kyba M, Metzger JM, Koyano-Nakagawa N, Garry DJ.
, S2 M7 B, l' w. V3 GSourceLillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.- d9 g& `$ Q% U& ?

/ i7 M- ~# J; V3 E/ f$ o1 `PMID: 21989919( ~' [0 D4 G9 I+ [& T1 _
http://www.ncbi.nlm.nih.gov/pubmed/21989919

Rank: 1

积分
17 
威望
17  
包包
79  
沙发
发表于 2011-11-4 09:39 |只看该作者
1      ER71 directs mesodermal fate decisions during embryogenesis. 参考中文标题: 点击查看机器翻译 作      者: Rasmussen TL. Kweon J. Diekmann MA. Belema-Bedada F. Song Q. Bowlin K. Shi X. Ferdous A. Li T. Kyba M. Metzger JM. Koyano-Nakagawa N. Garry DJ. 全文及相关链接:HighWire Press     Swets Information Services     摘      要: Er71 mutant embryos are nonviable and lack hematopoietic and endothelial lineages. To further define the functional role for ER71 in cell lineage decisions, we generated genetically modified mouse models. We engineered an Er71-EYFP transgenic mouse model by fusing the 3.9 kb Er71 promoter to the EYFP reporter gene. Using FACS and transcriptional profiling, we examined the EYFP(+) population of cells in Er71 mutant and wild-type littermates. In the absence of ER71, we observed an increase in the number of EYFP-expressing cells, increased expression of the cardiac molecular program and decreased expression of the hemato-endothelial program, as compared with wild-type littermate controls. We also generated a novel Er71-Cre transgenic mouse model using the same 3.9 kb Er71 promoter. Genetic fate-mapping studies revealed that the ER71-expressing cells give rise to the hematopoietic and endothelial lineages in the wild-type background. In the absence of ER71, these cell populations contributed to alternative mesodermal lineages, including the cardiac lineage. To extend these analyses, we used an inducible embryonic stem/embryoid body system and observed that ER71 overexpression repressed cardiogenesis. Together, these studies identify ER71 as a critical regulator of mesodermal fate decisions that acts to specify the hematopoietic and endothelial lineages at the expense of cardiac lineages. This enhances our understanding of the mechanisms that govern mesodermal fate decisions early during embryogenesis. 参考中文摘要:Er71 nonviable突变和缺乏胚胎造血和内皮血统之中。进一步而言,需定义的功能作用在ER71细胞谱系的决定,我们产生转基因小鼠模型。我们策划的转基因小鼠模型Er71-EYFP通过熔断3.9 kb Er71赞助人EYFP记者的基因。使用FACS和转录的评价,我们仔细检查了EYFP(+)人口的细胞突变的、Er71野生littermates。在缺乏ER71,我们观察到一个数量的增长EYFP-expressing细胞,增加表达式的程序并减少心脏分子的表达hemato-endothelial程序,相比而言,野生littermate控制。我们也产生了一个新颖的Er71-Cre转基因小鼠模型使用相同的3.9 kb Er71推销员。研究表明,遗传fate-mapping ER71-expressing产生造血细胞和内皮血统的野生的背景。在缺乏ER71,这些细胞群体选择了mesodermal血统,包括心脏血统。延长这些分析中,我们使用了一个诱导胚胎干细胞/混合而且发现生命的性体系统ER71压抑的cardiogenesis品系。在一起,这些研究确定ER71作为一个至关重要的调节作用mesodermal命运决定说明造血和内皮血统的代价心脏血统之中。这加强我们对mesodermal决策机制控制命运的早期胚胎。出      处: Development (Cambridge, England). 2011年138卷21期4801-12页 相关链接: PubMed Google学术搜索 Google引文 外部引文 相关文献 引文追踪(Google)

Rank: 1

积分
0 
威望
0  
包包
818  
藤椅
发表于 2011-11-6 13:17 |只看该作者
回复 chleiwu 的帖子: ?# R) f+ K- m* \. t! w

2 G# `& j  y  W( [; v& `4801 RESEARCH ARTICLE2 r* h& ~* f9 r6 L; L
INTRODUCTION
0 ~3 S6 L" P# yTranscriptional networks, signaling cascades, microRNAs and* _! x) k! u" p
other factors coordinately regulate stem and progenitor cell8 q9 g* m0 G& J1 y& p9 x  X: b
populations to give rise to the mesodermal lineages (Davis and Zur# Z: E+ S$ @. _5 T- ?
Nieden, 2008; Ivey et al., 2008; Omelyanchuk et al., 2009; Park et
& e; L! D3 Z* C1 r, w. v. Fal., 1998). During embryogenesis, a set of anterior progenitors2 j: i  b7 o5 i7 @+ ^5 B( I3 Y: E" K
coalesce to form the heart. These progenitors, along with the blood+ i8 f* ]7 o' \' ~8 A
and vasculature, comprise the circulatory system, which is the first
2 `* F1 F, |# |* I  ^1 ?, A$ corgan system to develop in mouse and human. Disruption or& j8 ?- z' p, [7 K1 A
elimination of any one of these lineages results in early embryonic. X& y! `( g( c. g
lethality. However, the factors that regulate the co-emergence of/ t2 f8 ]7 t7 A7 J  f6 S/ Y  E
these lineages from the mesodermal progenitor pools are7 G0 {) E# w( q4 ^
incompletely defined.
1 S7 ~& r1 W  }7 c, ^* z" IRecent studies have identified a multipotent progenitor cell. h9 ?# q0 f6 n# n+ s
population that is capable of giving rise to the cardiomyocyte and
, H( l, l( S' @& W4 Fendothelial lineages during embryogenesis (Kattman et al., 2006;' v& k* |) N0 n8 k! ~1 j
Moretti et al., 2006; Wu et al., 2006). Although these multipotent0 r2 {6 B/ U0 N: P: w
progenitors have been identified based on the expression of Flk1
$ v& a$ D7 r  a7 P! Y4 b' n9 ~(also known as Kdr), Nkx2-5 and Isl1, the transcriptional networks6 m6 \" h' Y/ ]/ r. r2 O+ r  S+ j
that govern the fate of these progenitors are unknown. These and
2 Y& s" a$ M& Q2 {3 m/ t2 `! wother studies emphasized the plasticity and context dependence of1 f# b9 |5 l7 p# D
regulatory cascades in the progenitor cell populations. For example,' U" Q4 w, Z8 _" l! w7 F8 @
our previous studies demonstrated that Nkx2-5 has a dual
1 o# Y. K4 F- e- C& m! ctranscriptional regulatory role in the promotion of the cardiac
4 I6 \  C: D0 Tlineage and suppression of the hematopoietic lineage (Caprioli et( S$ T5 t9 f3 |5 b" W4 w  h
al., 2011). In this fashion, we proposed that the stoichiometry of) N1 |& q/ C5 K- E" y5 x, ]1 Q& i$ A
regulatory transcription factors and interacting factors could; b! `8 \* U' r
dynamically regulate the fate of progenitors. Definition of
+ J& ^$ J: \( [! ^+ V9 g7 nadditional networks and signaling pathways that promote and9 K, \. g8 O# q& X+ R, K7 C! F
suppress the fate of distinct lineages that arise from multipotent/ _6 I; s; w- f, O% B1 \  r
progenitors will enhance our mechanistic understanding of their
3 _8 m0 z3 p) k; ?" |$ X& ^0 W7 Ddevelopmental potential.& @0 `8 u5 C; m$ ^
Ets-related protein 71 (ER71; Etv2) is a member of the Ets; t8 z9 N; j- K) L' Q7 w7 Y9 V% v
transcription factor family that we and others have shown to be
  ~+ }" n, m8 U% L8 K3 gessential for formation of the endothelial and hematopoietic
$ g  I* S3 P" b( k- K! |9 Nlineages (De Val et al., 2008; Ferdous et al., 2009; Lee et al., 2008).+ h0 X8 M( k# f5 _2 h
Er71 can be induced by BMP, Wnt and Notch signals to promote
8 F1 g- V& k: ]  f9 j8 chematopoiesis (Lee et al., 2008) and synergizes with FoxC2 to
8 T2 v( {  y0 iregulate the endothelial program by directly targeting Scl (also1 [. a/ u% \- y# U0 [
known as Tal1), Notch4, Cdh5 and Tie2 (also known as Tek) (De9 E# y) P3 u# K3 Y1 Q& l
Val et al., 2008; Ferdous et al., 2009; Lee et al., 2008). In Er71
7 a2 X4 i. c8 L$ f/ ymutant mouse embryos, there is a complete lack of hematopoietic
( E/ `/ R3 i) H. F& |+ Z4 C5 iand endothelial lineages and the embryos are nonviable by+ j* ?* T/ b& Z( U+ `% W
embryonic day (E) 9.5 (Ferdous et al., 2009; Lee et al., 2008).9 e: Y$ v; o0 ]( \
Analysis of the Er71 mutant embryos revealed no differences in
7 _( Y  i  D" o! m+ [' scellular proliferation or cellular apoptosis compared with age-
% H$ c$ x' k8 Z- c1 p# K3 Omatched wild-type littermates (Ferdous et al., 2009). These results, x  [, y& t% d+ @, s+ Z
raised the question of whether the hematopoietic and endothelial
  k9 c9 Q; U: U+ @' K, I3 y  ]' Tprecursors are still present but unable to differentiate to hemato-! k+ q' o% Q0 ~! Y
endothelial lineages, whether they had been redirected towards% B+ z4 P7 `9 w( n0 t& }
other lineages or whether these cells never arose during
$ H  ^3 C* V0 ]1 cdevelopment.
  W! J5 Z$ \* v: ~Development 138, 4801-4812 (2011) doi:10.1242/dev.070912
" o+ D$ D3 g9 m/ }© 2011. Published by The Company of Biologists Ltd
* m. L& T0 l' U' @* E6 S$ H1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA.! `' b* {+ v; M
2Department of Integrative Biology & Physiology, Medical School, University of7 h; y: t- A, a5 ]7 O( x
Minnesota, Minneapolis, MN 55455, USA. - ]$ l" ?4 `0 G/ d. Z" N7 G$ K
3Biolead.org Research Group, LC% y6 H% z, k! h9 `$ p
Sciences, Houston, TX 77054, USA. + g+ l# z: o, m( \/ y
4University of Texas Southwestern Medical
) T, R% Z! Z3 i( u$ B& j9 sCenter, Dallas, TX 75244, USA.2 H: J3 M7 m' P' H$ l: N
*Author for correspondence (garry@umn.edu)
2 I% P5 Q2 `& t. |6 _Accepted 5 September 20118 G% g  u" X: L$ j' K" N# [
SUMMARY
9 ]9 o! H! Q( o) K7 v; a6 [7 ?/ ]Er71 mutant embryos are nonviable and lack hematopoietic and endothelial lineages. To further define the functional role for
  z3 w, z  p' z$ j# `/ g" _  }6 yER71 in cell lineage decisions, we generated genetically modified mouse models. We engineered an Er71-EYFP transgenic mouse
+ q$ _8 W& I" p6 Pmodel by fusing the 3.9 kb Er71 promoter to the EYFP reporter gene. Using FACS and transcriptional profiling, we examined the
: K3 D' n& |& v  LEYFP+ population of cells in Er71 mutant and wild-type littermates. In the absence of ER71, we observed an increase in the& V  K- b1 H- f8 f( P7 u
number of EYFP-expressing cells, increased expression of the cardiac molecular program and decreased expression of the hemato-
4 h" g7 z* `; k% T0 mendothelial program, as compared with wild-type littermate controls. We also generated a novel Er71-Cre transgenic mouse" Q+ X" j( }, O* r% c* s4 X
model using the same 3.9 kb Er71 promoter. Genetic fate-mapping studies revealed that the ER71-expressing cells give rise to the
% y; P1 B5 `$ m1 n- t  B. Phematopoietic and endothelial lineages in the wild-type background. In the absence of ER71, these cell populations contributed$ h; S1 N" w4 I( _
to alternative mesodermal lineages, including the cardiac lineage. To extend these analyses, we used an inducible embryonic2 K2 }* ]) U+ g
stem/embryoid body system and observed that ER71 overexpression repressed cardiogenesis. Together, these studies identify ER71
# e# s  M, F, zas a critical regulator of mesodermal fate decisions that acts to specify the hematopoietic and endothelial lineages at the expense
+ H/ d  M2 u$ [% j# W4 ]of cardiac lineages. This enhances our understanding of the mechanisms that govern mesodermal fate decisions early during
* Q; a% i/ m7 ^embryogenesis.
! k& Y0 a( x% ~% qKEY WORDS: Transgenesis, Er71 (Etv2) knockout, Mouse  t2 j" J- I1 L% l0 j. z0 g6 S
ER71 directs mesodermal fate decisions during
) u% C3 H6 L2 R5 L( o0 Rembryogenesis# }: ]5 ^4 r3 F( d4 G# |
Tara L. Rasmussen1, Junghun Kweon1, Mackenzie A. Diekmann1, Fikru Belema-Bedada1,2, Qingfeng Song3,
6 Q$ ?$ {  E% [9 w! z7 G0 I1 XKathy Bowlin1, Xiaozhong Shi1 d! Z9 G3 v, x
1, Anwarul Ferdous4, Tongbin Li7 q1 s; Y, p. o
3, Michael Kyba1, Joseph M. Metzger1,2,
* X6 T$ e& s5 _: s& c. FNaoko Koyano-Nakagawa1 and Daniel J. Garry1,3 R3 m; R2 O7 Z; D! ?" O; e' D
*
, x/ M4 u' H& h. FDEVELOPMENT4802% e: B: x! Q! t
In the present study, we have dissected ER71-mediated
) T% N5 v2 w9 f& m! emechanisms that govern fate determination during murine
' y/ W- _' ^7 i8 O3 Nembryogenesis. We have generated a novel transgenic mouse) J4 s6 Q) m3 w/ L9 s  K& N
model in which the 3.9 kb Er71 promoter drives the EYFP reporter
1 O: @: B5 y/ V+ W- h# ](Er71-EYFP), and crossed it into the Er71 wild-type and mutant
0 |/ h; I$ Q4 P5 F" ?0 z8 nbackgrounds. This strategy facilitates the isolation and
. Z6 w% ?2 p! f7 v: u/ V; V4 |characterization of cells that would normally express ER71 from
' V" V' W* c7 x3 N" ^9 W3 W2 wEr71 mutant embryos. In the absence of ER71, we observed the5 `. w" E- \9 Z* B
conversion of cells that would normally give rise to lateral plate# S  a# A# q) ]3 E' H
mesoderm into cells that produce paraxial and cardiac mesoderm.. ?' {( K% e& \
Furthermore, ER71 overexpression in vitro using an inducible7 H& |) g: w; E9 d
embryonic stem cell/embryoid body system demonstrated  O: Z) X5 a1 U: _) d
decreased cardiogenic potential. Collectively, these data
7 P8 K* G8 N3 _2 s# V/ J: zcomplement and extend our understanding of the functional role of
4 d9 s, C! N2 f9 }ER71 to differentially promote mesodermal fate decisions during
  k+ \- _: |# D5 b# Dembryogenesis.
2 Y. z: z" Z' Y  n( e! d) [- {' yMATERIALS AND METHODS
) S- l* |: Y; ?# a# sGeneration of transgenic mice
! A3 R- k: h( o& }! \' WThe 3.9 kb  Er71 promoter (Ferdous et al., 2009), which harbors the
5 a1 M6 w3 `2 w7 zmodules necessary to direct the temporal and spatial expression of ER71,. h2 [9 |- N3 O: D) e3 q' R9 E" ]
was cloned into the pEYFP-1 vector (BD Biosciences) and into a2 f/ N8 J" P: D9 @' r% A
promoterless pBS-Cre-pA vector to generate the ER71-EYFP and ER71-
. g6 E, i% Y& X" e+ MCre constructs, respectively. Transgenic animals were generated at the
1 N9 Y" A. b7 A2 W5 q, kUniversity of Minnesota Mouse Genetics Laboratory using standard& `: `) J% W! o5 C) P. H# _
methods. Transgenic mice were screened for DNA integration by PCR.  X# d8 z- ^* B4 S$ v2 Y
Expression analysis of ER71-EYFP lines was performed by examining
& p' L% b  Q3 W( Q+ U6 {* `E7.0-9.5 embryos resulting from timed matings to wild-type CD1 mice
8 T3 A/ V+ ^+ }) v2 ^- E5 T(Charles River). We also analyzed E11.0 and postnatal day (P) 3 offspring
  B! p! U) I4 A# `of timed matings of the ER71-Cre lines and the Rosa-EYFP line (Jackson) n- [) @9 k* s- r
Labs 006148). Founder mouse lines were crossed to the  Er71
' {4 A( Y+ ~* r2 qheterozygotes previously described (Ferdous et al., 2009). In all cases, at
, h9 j; |) f1 B% Z4 _2 C; z% mleast three transgenic lines were examined to confirm similar temporal and
2 s9 o2 V. a/ @0 q8 `) zspatial expression patterns. All mice were maintained at the University of3 D0 J8 e( o4 ]4 C1 B: j
Minnesota under protocols approved by the Institutional Animal Care and
  ^1 |5 ~; v! S+ X0 Q+ m( iUse Committee and Research Animal Resources.9 y9 R- ^8 m) M! N1 U; o8 ^* f
FACS analysis
& u! s! P  j4 G) l1 IEmbryos from timed pregnant females were harvested at specified stages.
4 k2 U; X7 g2 R7 n  N+ _Embryos were separated from yolk sacs, which were used for genotyping,
1 x  j5 M$ }" E& Xand imaged on a Zeiss Axio Observer Z1 inverted microscope prior to
" P- O& U% N/ Zdissociation. Embryos between E7.5 and E9.5 were digested in 30-50 l
$ D4 W$ t1 U" I& o& v0.25% trypsin plus EDTA at 37°C. Digestion was arrested with 500 l) ^; u$ @  A' d# U: _$ J2 I, m
DMEM containing 10% fetal bovine serum (FBS). Cells were pelleted at3 l0 \. A% K: w0 p- U2 w
4°C (1600  g), resuspended in PBS and passed through a 70  m cell
. F5 s4 f: P7 ~& B: M( ?strainer. Cells were incubated with antibody cocktails for 30 minutes,
  d# Y+ i3 M* Q8 f8 r+ owashed, and resuspended in PBS. Cells were analyzed or sorted using a+ `) O, K8 Y* D/ B8 I5 s1 @# T, U
FACSAria (BD Biosciences). Various combinations of antibodies (1:1000)3 W4 d, D$ i, W! L8 J: K8 b
were used, including Flk1-APC (eBiosciences 17-5821), Pdgfra-PE' N" ~( Z$ M& Q% T
(eBiosciences 12-1401), CD31-PECy7 (eBiosciences 25-0311), CD34-PE9 X5 f( Q/ g( j/ P. P, v
(BD Pharmingen 551387), cKit-APC (eBiosciences 17-1171), CD41-' Y' H; \! J' l9 }% q
PECy7 (eBiosciences 25-0411), CD45-PE (BD Pharmingen 553081),
4 _' @. }, i3 A/ G0 s' l2 Q; pCD45-PECy7 (eBiosciences 25-0451-81), and Ter119-APC (BD( y: }& |3 b8 K
Pharmingen 561033) antibodies.
; N5 c/ a+ ]1 A0 S2 y. B$ F7 STranscriptome analysis
) A- g; P* n5 l  H2 H% C8 qTotal RNA was isolated from 1000-5000 FACS sorted cells in TRIzol+ w& c2 ~  W1 U: M$ i4 ?
(Invitrogen) using the PureLink Mini RNA system (Ambion). RNA was
0 F( D% `$ k' s2 S; X* A! Zsubjected to two rounds of amplification using the MessageAmp II aRNA- ]1 L' k, g$ e! \- @; l4 f' q
Amplification Kit (Ambion) and then labeled using the MessageAmp II-# x) x" W4 i, R5 m) }
Biotin Enhanced Kit (Ambion) according to manufacturer’s protocols.& G- \' s0 I/ u
Amplified RNAs were hybridized to Affymetrix mouse 430 2.0 full genome
8 [  ^6 U3 z  r) z1 R, D! {array chips at the BioMedical Genomics Center of the University of
2 }8 g2 o+ `, C3 p- H+ ZMinnesota. The CEL data files produced from Affymetrix array experiments
+ c! Q5 L) I9 j, [were processed using the affy package included in Bioconductor. The robust4 m( b2 z  ^  t0 K4 t9 M& I  G
multi-array (RMA) method (Irizarry et al., 2003) was used to perform data! }0 W4 C: w. |$ s' ^6 C
normalization, background correction and expression quantification. The
4 A0 D# g. f) a0 |3 Ylimma package (Smyth, 2005) was used to identify differentially expressed1 w+ r% r5 p$ K
genes by ANOVA analysis, and false discovery rate (FDR) values were
& a! q3 f  a( U/ x# ]. hcalculated using the Benjamini-Hochberg method (Benjamini and Hochberg,: Z6 D! y: `& }# W+ d
1995). Average linkage hierarchical clustering analysis was performed using
9 p$ }+ S) c0 `! `the cluster program (de Hoon et al., 2004), with uncentered Pearson’s; a+ u8 V  w$ p4 K& q2 @
correlation coefficient used to define pairwise similarity in gene expression.% d6 _4 `7 Z3 g: A
Genes annotated with the gene ontology (GO) term ‘heart development’# w" Q# f& y0 b, X8 {: U
(GO:0007507) were downloaded with AmiGO tool (Carbon et al., 2009) and
1 W$ j* @* _# f0 N8 }% `0 X! c) n+ Aused in producing the heatmaps. Microarray data is accessible in Gene' O, l; S. H6 ^# F
Expression Omnibus (series GSE32223).$ A& j+ z1 \) W7 ]
Quantitative RT-PCR
% C. Q1 G) a- i" dTotal RNA was isolated from 1000-5000 FACS sorted cells or embryoid
+ ]6 i, N- M6 r" L) }' jbody cells in TRIzol (Invitrogen) using the PureLink Mini RNA system.
* Z% b+ m; f, ?$ BRNA from FACS sorted cells was subjected to two rounds of amplification8 }4 p, O6 z& ?
as described above, but left unlabeled. cDNA was made using random. I5 t! h! |9 l# W3 \! `8 b1 b
hexamers and transcript levels were determined using VIC-labeled (Gapdh,
  h  \  b, x* T5 A9 g4352339E) or FAM-labeled (Er71, mm01176581_g1;  Scl,
9 a' `3 R0 l( i( D1 Lmm01187033_m1; Cdh5, mm00486938_m1; Gata4, mm00484689_m1;- o6 L" \- v: n5 q# R( z8 W
Tbx5, mm00803518_m1; Tnnt2, mm00441922_m1) TaqMan probe sets
* [1 ~, l2 ]- s8 H, c6 I(Applied Biosystems).
& o" v# H' d! C( {8 hEmbryoid body differentiation and ER71 overexpression
" y: o6 l" z6 t* b3 wDoxycycline-dependent ER71-overexpressing mouse embryonic stem
6 u5 x, h' Z# j/ t3 C: Z(mES) cells were generated using an inducible cassette exchange strategy& J& F* p% W3 I; Q2 U3 G
(Iacovino et al., 2009). In this system, ER71 tagged with a C-terminal HA
" m: M/ P: [" e& ]% Z0 Bepitope was overexpressed in response to 0.5 g doxycycline. To mimic
3 ]/ J; \/ D1 o/ L& w: M# T" E0 [2 p8 learly embryonic development, the mES cells were differentiated into
0 P% Y4 x9 B; F8 [0 Membryoid bodies (EBs) using mesodermal differentiation media [1.5% FBS1 Z9 i2 b1 M1 H( r& P2 @
(Stem Cell Technology), 1 penicillin/streptomycin, 1 GlutaMAX
' Z9 d. T2 `% C8 Y$ K(Gibco), 100 g/ml Fe-saturated transferrin, 450 mM monothioglycerol, 50
5 @7 G& F# o1 }) ~1 B! \6 Eg/ml ascorbic acid in IMDM (Invitrogen)] (Kennedy et al., 1997). ER71* f9 c7 G9 ^* E& M
was induced on day 3 after initiating differentiation and maintained through; h" r$ |+ p& X
day 10 by supplementing the differentiation media with doxycycline. On, Y+ |# o* b4 ]  W) j
day 10, we fixed the EBs with 4% paraformaldehyde (PFA) and prepared+ c4 d4 V$ W5 }2 d4 ?, N/ T  ^, ^
cryosections. We stained adjacent sections with Hematoxylin and Eosin
. z  h3 u3 m( x! {5 Y* E, Fusing a standard protocol and performed immunostaining with mouse anti-
+ J6 A; Z/ s% TTnT serum (1:200, DSHB clone CT3). We assayed the TnT-expressing area
1 H/ ^: T# L* o4 ~( O3 Y) [% j! s: Yof each EB using ImageJ software (NIH) and calculated the ratio of the
8 }2 D6 b2 q9 {7 O$ Upositive area to the total area from 33 sections of uninduced EBs and 42
4 C4 z4 q! t3 g+ A8 q; K: Tsections of induced EBs. EBs were placed on laminin-coated coverslips
/ l6 Y8 E! ^5 N" hand stimulated at 1 Hz. Edge detection (Ionoptix, Milton, MA, USA) was6 x; |* \5 f, w5 B1 W! u2 y6 Q3 x
used to measure contractility of intact EBs.% [1 e! W! l: E8 l( A( W
Immunohistochemical analysis3 i" N- {' P2 i3 Q
Stage-specific embryos were harvested from time-mated pregnant females.
+ r4 j2 |' B3 U. t7 \. g+ ]+ DFor paraffin sectioning, embryos were fixed for 4-8 hours at 4°C in 4%* k+ ]0 a0 ?5 x- P8 A' J" A
PFA and embedded. For cryosectioning, embryos were fixed for 1 hour at* \1 q4 V% A0 H* q) S
4°C in 4% PFA and embedded in OCT compound (Sakura). Sections were
/ \# o: E( n9 I% ~* q/ Z# _9 P) ]% k( Pblocked with immunohistochemical diluent (2% normal donkey serum, 1%
6 q  i& A, I! u* d# abovine serum albumin, 0.3% Triton X-100, 0.02% sodium azide in PBS,  W, n% x2 Q' t" U, z
pH 7.3) at room temperature and incubated overnight at 4°C with primary5 F0 t8 G! x1 R* y* z; ]
antibodies, including chicken anti-GFP (1:500, Abcam ab13970), rabbit, C9 ]  ]) ?$ b$ Y& D) k& K
anti-desmin (1:200, Novus Biologicals NB120-15200), rat anti-Tie2 (1:100,/ @9 x1 q2 E  F
eBiosciences 13-5987-81), rat anti-Pdgfra (1:200, eBiosciences 12-1401-
1 Y3 {/ g2 n- \6 b# |% t: t81), goat anti-Nkx2-5 (1:500, Santa Cruz SC-8697) and anti-CD41 (1:100,
, W9 y6 p: S' F0 bBD Pharmingen 550274), anti-Cdh5 (1:100, BD Pharmingen 55289), anti-" G2 {% Y3 _' x. o* b% y8 y2 N
CD31 (1:200, BD Pharmingen 550274), anti-Gata1 (1:100, Santa Cruz SC6 A8 y  J; X  V4 V1 W+ ?
265X) and anti-troponin T (1:200, DSHB CT3) sera. Slides were washed
& o  w! y7 E- a9 B+ C+ E0 e$ fand incubated with combinations of secondary antibodies (1:200) including
2 y4 N2 ~0 n& m+ [9 X1 panti-chicken Dylight 488, anti-rabbit Cy3, anti-mouse Cy3, anti-rat Cy30 R: l0 D& d' o3 a" K
and anti-goat Dylight 549 (Jackson ImmunoResearch Laboratories).+ ~: W, m' Z7 Q- N. P  e, P
Results were imaged on a Zeiss Axio Imager M1 upright microscope or a
3 W" Y) O2 K3 [) t( ~; OZeiss LSM 510 Meta confocal microscope.5 G+ I9 X3 u' E' z( l9 p5 Z" L# l# U, `
Statistical analysis
0 K# S% f" i7 u3 N* ^Data represent the average of at least three replicates and s.e.m.# u$ ^4 t, J" q; D
Significance was tested by the Kruskal-Wallis test with the Dunn multiple4 M$ J6 G# ~/ u7 X/ T6 g. V
comparison test for more than two groups; for example, when comparing
2 W9 T5 [1 E2 l# vRESEARCH ARTICLE Development 138 (21)
3 X, i& t/ v, N' o0 K+ dDEVELOPMENTwild type, heterozygous and homozygous mutants. Significance was tested5 x  O) j% p& i. i% A! b' ]/ U
by the Mann-Whitney U test for two groups. Analyses were performed
: l- ^& R+ @  L6 rusing Prism5 software (GraphPad).
& t- ]9 _% _& ?4 b& I* X9 y# d! U! TRESULTS) y; C  [! b( m8 s4 Q
Expression analysis of the ER71-EYFP reporter
6 \; {' ~' F6 H/ _Initial analysis of ER71 expression in the developing mouse4 M  f2 x$ H/ f: t
embryo was reported previously (Ferdous et al., 2009; Lee et al.,
$ g- k' f7 q/ W) R2 g2008). To further examine its potential role in cardiovascular4 G+ l& c/ \" q! h8 k, Y5 ]9 C
development, we performed a detailed expression analysis of ER71
3 I8 J5 ]- \7 S( ofrom E7.0 to E9.5, when Er71 mRNA is expressed (Ferdous et al.,
' Q& q# R* f8 [, @* Q3 s9 ^7 w2009). None of the commercially available ER71 antibodies
% J- p" S+ l( Pdetected the endogenous protein, so we utilized an Er71 transgenic# o8 j" [4 n! M* E' D
mouse driving an enhanced yellow fluorescent protein (EYFP)
1 I: \% ~1 D$ d" @- E! rreporter. The 3.9 kb region upstream of the Er71 transcription start3 N2 L4 Y1 q$ {. p; J# T( G) x
site was fused to the  EYFP reporter (Fig. 1A). This promoter4 m% e' G1 B8 {; B( g( T4 O+ f7 L
fragment was previously shown to drive reporter expression that
. k/ f' X- f4 Q* A- B$ o" Brecapitulated endogenous ER71 expression (Ferdous et al., 2009)., ]1 W$ U) n7 D  r& V$ O7 F5 `
Four founder lines were generated with offspring embryos that
  T0 L6 d1 N. ~* wshowed the same expression pattern.
- \& R! n8 c  YTo examine the expression pattern of the EYFP reporter, we9 E, P+ r4 o6 i. H' V8 L
compared its expression to that of the angiopoietin 1 receptor Tie2,  L; l. A% F6 ]& r8 K5 d3 d1 y+ v4 Z
which marks endothelial cells in mice and humans (Dumont et al.,
- n; ~4 T1 Z# I5 j6 `1992; Sarb et al., 2010; Schlaeger et al., 1997; Schnurch and Risau,% S- y  @. `' Z$ w
1993). The EYFP reporter (representing ER71 expression) was4 a# z, ^% T$ X& P
expressed as early as the early to mid gastrulation stage (E7.0; Fig.
9 x% M" w% b3 J0 d3 b. n1B, bracket). At this stage, reporter expression was limited to the- n0 {9 K6 x9 Q! X: ?( q
extra-embryonic mesoderm (Fig. 1C) and showed co-expression
6 ?& m" W' Q0 ~, ]4803 RESEARCH ARTICLE ER71 governs progenitor fates1 c( g# }7 O+ V) B, J: l* l
Fig. 1. The transgenic ER71-
; k& R* L- L6 L! s5 ~% G/ EEYFP reporter is expressed
4 h+ e4 x" x. A) B0 \during embryogenesis.$ ]' x4 I  D: X( Z+ i) L' ]
(A)The transgenic Er71-EYFP+ e0 K5 i4 P+ O9 Y" L& v( M" {& K
construct used in these analysis.
2 e- U1 t% h% j1 x8 x(B-Q)Expression analysis of mouse/ ?3 \* \+ @3 @( @+ q0 B
embryos between E7.0 and E9.5.
5 O( S! r+ y, G. a- |2 O0 LEYFP protein fluorescence (green)
" V( B1 W, b* P+ \: w: U2 j2 D7 vis shown in whole-mount images
' p% Z  \% E; x1 o* e(B,D,F,J,K,N). Sections were
# i: a  ^1 x9 `9 K  _4 qstained with anti-GFP (green)," b; U+ }$ L1 _; j; @- u: Y
anti-Tie2 (red), anti-Nkx2-5 (red)
+ a" h* ?6 j( P# L5 O- dor anti-Pdgfra (red) antibody as/ I& y3 {8 }+ S/ |! \' c& X
indicated. DAPI nuclear staining is
' d; P3 G8 @/ N3 Hshown in blue. Yellow indicates
7 i) S  z2 `8 Woverlap of green and red& F. l- x3 s4 ?' r8 h: M
channels. (B-C) Early to mid
0 P+ _) D2 f+ A  `, wstreak stage, (D-E) early bud/ d9 A; Y& s/ |& s
stage, (F-I) early head-fold stage,
; }0 S, z$ D  e# c(J-M) E8.5, (N-Q) E9.5; embryos
  a2 a* w1 P( b, u1 t& M1 t3 M' hwere staged according to Downs
# M, }: ?- A: t% J1 xand Davies (Downs and Davies,
: J, l6 R. @5 _" ]! A1993). Boxed regions are shown
+ a2 e& e; U4 E7 j; n2 J) tat higher magnification; planes of
6 ~3 Q8 U, O5 W% }sections are indicated. See first9 i# n: J1 i( h( I. l1 s
section of the Results for a
, r  @, G" \" c: x8 z4 w3 H7 M* ?description of arrows, arrowheads
$ t1 l( b/ j8 \. z: y' J& p* I" sand other labels. al, allantois; ba,
4 u* t3 j5 b" z3 pbranchial arch; bi, blood island;
5 B" Y& l, l0 A* Y" zcc, cardiac crescent; cv, cardinal+ K/ _/ z+ w" j: e" r' G% ?& `0 s
vein; da, dorsal artery; ec,. k% E& ~4 R  B5 |5 W
endocardium; h, heart; hf, head
2 _7 Y2 f2 P4 w8 M# o2 k/ Jfold; np, neural plate; nt, neural7 s0 Y3 z) x, l/ ^6 A
tube; ph, pharynx; pm, paraxial
3 E- C8 F3 P8 X$ V. z8 ?* `mesoderm; s, somite; ys, yolk sac.+ K! k! V) @: |/ d% H# P4 L6 w2 L
Scale bars: 200m; 50m in
: i, S4 t3 _& X7 A2 renlargements.- Q1 v- g: T4 Y
DEVELOPMENT4804$ l0 L; P3 N" t5 z/ g# o2 N
with Tie2 in the primitive blood islands (Fig. 1C,C, arrows) (Ema
! C, o) X! z, w! p6 X! Z% {5 ^; \% {et al., 2006b). EYFP was also weakly expressed in the mesothelial  n6 ?# y7 ]7 R3 L
layer of the yolk sac, but Tie2 was absent in this non-endothelial3 A+ a% r+ L, u8 r# |
cell population (Fig. 1C,C, arrowheads). At E7.5, continued
9 w) L9 C6 [  g; q6 i; Yexpression of the EYFP reporter was observed in the extra-/ q2 d7 I3 ^" @6 O. N2 l! \* I" x2 }
embryonic mesoderm (Fig. 1D, bracket). In addition, scattered; `7 V6 V: N- Y0 m7 V
EYFP+ cells were observed in the lateral plate mesoderm (Fig. 1D,
# [$ |0 P% X' K" r, garrows). Transverse sections showed that these scattered cells co-
  p- Y/ {. X" j" e! W8 f4 B0 Uexpressed Tie2 and most likely represent endothelial progenitors3 U4 V/ d& v5 }. q
(Fig. 1E,E,E), although Tie2 expression has also been identified
. L* C: O. F6 P2 o" Bin a subset of cells committed to the hematopoietic lineage* ^. ]( }8 ^" M$ c  d
(Kisanuki et al., 2001; Li et al., 2005).
5 M' T) ]- ^0 ^( k( g: sAt E7.75, the EYFP signal localized to discrete structures
, t& D, o8 I/ p$ {- Y# e9 `. ]including the cardiac crescent and the progenitors of the dorsal aortae) ]6 G+ j' Y. H0 Z! g
(Fig. 1F, cc, arrows). We examined the expression in the cardiac
2 U9 W1 r1 U8 a- e+ Y' d! h) `crescent and paraxial mesoderm in detail using Nkx2-5 and Pdgfra
# s+ D. F; X& O2 Y+ s( wantibodies (Fig. 1G-I). We observed that the EYFP signal overlapped7 a; X& d$ A$ P0 w5 J. ?' l5 {/ H; B5 _
extensively with Tie2 within the cardiac crescent (Fig. 1G,G).
' ~( Z" U7 c- e# k! G( T0 lThese EYFP+ cells are presumably endocardial progenitors (Misfeldt2 Y, |6 m0 w7 J6 j  J
et al., 2009). By contrast, EYFP+ cells either weakly expressed or did
  M- L1 ^& ]# l8 snot express Nkx2-5 (Fig. 1H,H, arrows and arrowheads,
% R# C: \# V# A+ b  J3 ]respectively). We did not observe strong co-expression of Nkx2-5
$ V3 m! Z1 g0 Oand EYFP. Pdgfra is strongly expressed in paraxial mesoderm and5 q; w2 b! v7 e8 C0 d; _3 V, y; G4 Y
cardiac mesoderm (Fig. 1I, pm and asterisk). Double. e+ z( s7 g: u! F
immunohistochemical labeling of EYFP and Pdgfra demonstrated& B; n2 E0 E. ]- Q
that most cells either did not co-express these markers or weakly5 b3 d3 z7 U: H' c& h; I+ N
expressed Pdgfra (Fig. 1I,I,I, arrowheads and arrows, respectively),
# b9 f) Z+ ]# {8 ]- Swhich is consistent with previous reports that the hemogenic lineage
, D# I, n$ J4 U: E+ \is segregated from the paraxial mesoderm early during gastrulation* B* J0 D% `( E
(Kataoka et al., 1997; Takakura et al., 1997).9 J& l+ q$ |2 u$ E) _5 S% U3 t
At E8.5 and E9.5, we observed localization of the EYFP signal to2 \2 T; G% F/ }* N/ A4 R4 F
vascular structures throughout the embryo proper (Fig. 1J,N; arrows
; k  L6 d7 M; g0 R4 w- Opoint to the dorsal aorta and arrowheads indicate intersomitic vessels)
/ Y/ a, t: q$ }7 J5 Qand yolk sac (Fig. 1K). Transverse sections of the embryos (Fig.
2 [! C6 D( E5 X1 S1L,M,O,P) showed localized expression in the vessel structures, X' E0 W5 o) F% K7 a1 M: v
including dorsal aorta, cardinal vein, intersomitic vessels! k0 w! |0 l8 |; h$ X
(arrowheads in Fig. 1M) and the endocardium (arrowheads in Fig./ r7 M0 l# S) A* {- {9 u! o/ @9 O
1L). The expression of EYFP largely overlapped with that of Tie2,( ^& c4 B6 }  H' `; u$ z0 j
indicating that the  Er71 promoter is active in early embryonic; q% u9 o2 y' H' _0 O/ o
endothelial and hematopoietic cells (Fig. 1O-P). We also observed
# ~* U$ Z8 ]- M0 Vthat EYFP was co-expressed with the hematopoietic transcription
$ B' p5 p1 I! W4 c2 `& Cfactor Gata1, the cell surface marker of hematopoietic progenitors; o$ O# ], w. E' Y6 U" W
CD41 (also known as Itga2b), the marker of hematopoietic and% E; l# y5 m( U( a
endothelial lineages Cdh5, and with the primarily endothelium-
' I9 r4 O1 w0 a3 z4 X; nspecific cell surface marker CD31 (also known as Pecam1)
4 K* Y7 V& m' A(supplementary material Fig. S1). By E9.5, Nkx2-5 was localized to
$ I/ Z$ g9 Q8 Vthe myocardial layer of the heart and did not overlap with EYFP
. V! V/ T0 k! h& u; f/ ~4 Y5 Kexpression (Fig. 1Q, arrowheads; compare with 1O).
8 r3 e! B2 f6 }( L  ZReporter expression is mislocalized in the Er718 u6 I; |9 `! o
mutant
& b7 P; j& c1 I8 p- zIn the Er71 mutant, the hematopoietic and endothelial lineages are
* O, o$ K1 u- Wabsent. However, no changes were observed in cellular
  ^7 `1 w( r" x! \' xproliferation or apoptosis in the Er71 mutant embryo (Ferdous et* ?8 J5 r* x* B1 O2 m* r# b
al., 2009). Therefore, we crossed the ER71-EYFP reporter line into6 ?6 \$ F  ?( B) W; g% P
the Er71 mutant background to define and characterize the cells+ u" W# j/ i4 f2 I
that should give rise to these lineages (Fig. 2). In the E7.75 wild-
9 K6 {% N8 Z: ytype embryo, EYFP expression was observed throughout the6 Z$ |( J+ C9 {
cardiac crescent, the dorsal aortae and the extra-embryonic# {# k# k, }5 Q
mesoderm (Fig. 2A). By contrast, in the E7.75 mutant embryo the
: f. T5 }' _* d6 `3 y$ J+ Vexpression pattern was less definitive. EYFP-positive cells were- d6 y" S8 N4 z/ h& }
found in the extra-embryonic tissue; however, expression of EYFP
+ f% [. [7 @7 K! P, n3 J" {within the embryo proper was mislocalized (Fig. 2B, arrow). EYFP
9 ?' a. d* ~5 z0 X1 dexpression appeared diffuse throughout the cardiac crescent (Fig.7 E) Y3 V' t) G/ c$ B/ Y
2B, asterisk). In the wild-type embryo at E8.0, EYFP expression, e5 T4 F5 d! l/ k' }3 m
was observed specifically in the dorsal aortae, but not on the6 w0 i& o6 `; A% K( C2 h
periphery of the embryo (Fig. 2C, arrowheads). EYFP expression) p) D5 n9 J1 B: V* n" K1 \
was also observed in the presumptive endocardium within the; `% e' R8 w) _) N  I% ~
linear heart tube (Fig. 2C). By contrast, the Er71 mutant embryos
# d3 b6 n+ ~1 o( X; Iexpressed EYFP only at the periphery of the embryo, which is
; L' [7 K4 `) u/ q* V$ D) m% k4 rlikely to represent paraxial mesoderm (Fig. 2D).6 O3 Y. y. o  A0 @% y9 t
Immunohistochemical analysis of ER71-EYFP and Pdgfra, a9 B' U: P- x8 `% S- X& Q/ K
marker of paraxial mesoderm, expression in E8.5 wild-type and& h1 m- e* z0 l! |( K, l
mutant embryos demonstrates that EYFP-positive cells are
5 A  m; _4 v2 J9 u  {interspersed within the Pdgfra-positive mesoderm (supplementary
7 \! \& p! [" J: y  c2 T) g+ rmaterial Fig. S2). FACS profiling showed that the frequency of7 k% G( y" z: i2 {
EYFP+ cells was increased in the Er71 mutant compared with the' o, y- y, ?; L
wild-type control at E8.0 (Fig. 2G-I), but not at E7.75 (Fig. 2E,F,I).
  u' Y5 E* b( r9 u" ^: i( w1 |4 _The apparent increase in the percentage of EYFP+ cells could be
8 A+ ^. Z1 _7 K/ l4 pdue to a reduction in the total number of cells without a change in, i2 q, ~- }+ V; t
the number of EYFP+ cells, as cell viability can be reduced by a6 H0 g% N) X( g0 j( A' K4 M
lack of vascularization. However, we ruled out this possibility as
# z# W; I" r7 m7 K# jwe also observed a doubling in the absolute number of EYFP+ cells
9 w6 \4 [* M1 X' I+ gin E8.0  Er71 mutant embryos as compared with wild-type
; j. h' y* \, M3 u# k- x3 \! olittermates (Fig. 2J).0 e4 v# \9 D' v) v
These analyses demonstrated that cells that expressed the ER71$ p" W7 T6 z: E2 W, \( \- l9 j  c
reporter were not only present in the Er71 mutant embryo, but were6 M& q- S9 M" a! ?
also expanded in number. Since the Er71 mutant embryo lacks) d( R! [$ {( y9 d$ q
differentiated endothelial and hematopoietic lineages, we examined  {! @+ w# v; v% s8 d
whether these EYFP+ cells were arrested progenitors or cells( H& N0 l4 v' A, r% z+ i/ t0 a7 e2 N8 m
redirected to other lineages. We used FACS analysis to examine the
  O# k: r5 Q* f4 ^cell surface markers of the EYFP+ cells in the Er71 mutant and/ S9 w1 b& {7 v, R6 w% N$ x2 U
wild-type backgrounds. Previous studies have established that, `- t" G% r1 i, i
Pdgfra is expressed in the primitive streak at E7.0, but is restricted% Z6 t; y1 E6 o
to the paraxial mesoderm at the early head-fold stages (Takakura3 o' Y2 e; }) V, h8 D
et al., 1997). Flk1 is expressed more broadly in mesodermal, T  _* `$ S; j8 R3 e% I2 i* I: o
precursors (Ema et al., 2006a; Motoike et al., 2003), including the
3 Z3 W+ l( b+ rposterior portion of the primitive streak. Flk1+/Pdgfra–
; A; b" C/ }" M; Icells mark
, {; P/ ]' d1 B% H. nlateral plate mesoderm that will give rise to the endothelial and
/ ?8 P! \& o  K4 L% u8 w" S5 ihematopoietic lineages and Flk1–
. ]0 m: G' M0 s2 u' @6 j/Pdgfra+ cells mark the paraxial: M* W1 P# H# t# [
mesoderm. Flk1 and Pdgfra are known to be co-expressed in the  n) M' e! C% w3 p$ d
cardiac crescent (Kataoka et al., 1997) and in cardiac progenitors7 b7 `$ X, w) |! E3 S' }* T
of embryoid bodies (EBs) (Bondue et al., 2011; Kattman et al.,: f+ b7 N# T% I3 `# e
2006). In the present study, the frequency of Flk1+ cells within the
  K! ]1 o: T& [1 _& D" V) W5 E9 W8 QEYFP+ population was significantly reduced at E7.75 and E8.0
- f$ B, E, K& A$ n(Fig. 3A,B,D,F). CD41 (Fig. 3D,E) and CD34 (Fig. 3E,F)
1 x( i2 `* a  t3 L9 [8 K& s& M2 hexpression was essentially absent at E8.0 in the EYFP+ cells of the$ G4 M& F( q' a3 Q7 t
Er71 mutant. These results show that the lateral plate mesoderm5 ?/ p/ F  Y" ~3 |$ I) }, v: Q4 B
lineage and its derivatives, i.e. the hematopoietic and endothelial
4 `. c- H4 L& g5 elineages, are reduced in the Er71 mutant." }3 k4 _2 m: J1 r" X6 F) j
In order to assess which lineages are expressing ER71-EYFP, we$ O+ X$ H7 M5 x" Q+ q+ z
analyzed the EYFP+ cells using Flk1 and Pdgfra antibodies.
! q2 n) N4 f) wConcurrent with the decrease of Flk1 expression at E7.75 and E8.0,+ x2 X5 j2 c8 ~8 ?, K
we observed an increase in the frequency of EYFP+ cells that4 M( H: p2 s% \& O! k; D
express Pdgfra (Fig. 3A,B). This correlated with a significant
, [6 r$ i0 v  o- P% tincrease of Pdgfra single-positive cells at E7.75 and a significant3 Z7 U" Y3 T3 i8 w" F( X. `
increase of Flk1+/Pdgfra+ cells at E8.0 (Fig. 3A,C). There was also) {9 h1 x! F! G5 p
a trend toward expansion of Pdgfra single-positive cells within the5 _8 m$ e  z. t9 Q
EYFP+ population at E8.0 (Fig. 3A,C). To support these5 {  D8 P  ~- l: P, i4 \# A
observations, we used immunohistochemistry to analyze the EYFP6 z! R" T$ G4 B; }, ]7 K
expression patterns. In wild-type embryos, EYFP expression is+ D( h6 t8 h/ w  \
distinct from Pdgfra+ paraxial mesoderm. A select number of+ n2 f& Z6 d4 Z0 l' X5 s$ J/ r- c
EYFP-positive cells are found within this region; however, these
  r% k4 H! O  S. i. n5 d" m' r2 Wcells are Pdgfra–
7 O5 z* v3 Z2 u* ], a& ~(supplementary material Fig. S2A,B). In mutant. t* k1 x# ~  o6 j5 Y0 J% i( G
RESEARCH ARTICLE Development 138 (21)
3 L6 b0 x* A  d" F5 c& p" VDEVELOPMENTembryos, many EYFP+ cells are found within the Pdgfra+ paraxial
! a8 c$ G( C" {  U0 ]% q; P5 w5 w6 O; fmesoderm. Some of these cells are double positive for EYFP and
$ Z6 z0 q6 z. o/ K, T8 uPdgfra (supplementary material Fig. S2C,D). Likewise, in wild-5 N- D* V5 f# f6 Z: L
type embryos, EYFP expression is distinct from troponin T (TnT)
7 ~& p4 p  L1 b- D4 W* _+
) T' X4 E2 A9 g' c5 w# Dcardiomyocytes (supplementary material Fig. S2E). However, in
  Z& N; f1 M8 ?; J2 y/ f& h" Tmutant embryos double-positive cells are found (supplementary
' q' Q& |: q5 J3 H0 s8 s0 Z$ `/ zmaterial Fig. S2F,G, arrows). One interpretation of these data is7 u( t. b( n7 ~" ]: }: C6 c: t  |* r
that, in the absence of ER71, the EYFP+ progenitor cells
, v# F+ |* I' m5 ?% B/ Hdifferentiate towards the paraxial (Flk1–
0 b# R9 n/ J% O& N' l- i8 L3 v" s/Pdgfra+) and cardiac
+ B7 C( Z6 e5 h3 D2 z/ n7 a$ smesodermal (Flk1+/Pdgfra+) lineages at the expense of the lateral
$ c+ Z9 r# y& |/ Nplate/hemangiogenic mesodermal (Flk1+/Pdgfra–
2 @7 l# \- h" d2 @) lineage.
3 w; {: K% q0 `1 XAn alternative explanation of these results is that EYFP is; o1 e$ y6 k+ c6 V
expressed ectopically in cardiac (Flk1+/Pdgfra+) and paraxial
0 `2 {  A/ H. U+ [* [. K* P(Flk1–
+ y' k4 h9 z0 E& }: p6 X! e. O. t/Pdgfra+) mesodermal populations in the absence of ER71.
9 x3 Q) T2 A0 p8 M. Y& OIf this were the case, we would expect the cardiac and paraxial
2 x4 B) [# J: b# L8 n5 ?0 m! h4 Cmesodermal populations within the EYFP–
& y8 n/ {7 A5 `gate to decrease in
8 t; t) _( [0 Ithe mutant embryos because these cells expressed EYFP and- S+ e5 f- B5 @
would be included in the EYFP+ gate. Furthermore, we would6 q% f, @. I" k& H% p) ~
expect no change in the overall representation of these markers
& R) N$ b. T$ {. Iin the unfractionated (the sum of EYFP+ and EYFP–
. ]: |3 o0 {' W0 z' }! Y) gate. To
" f3 G1 _' [' Gexamine this possibility, we analyzed unfractionated cells from$ S* n) a% ^2 E: y+ P) `
the whole embryo as well as EYFP–+ l& D; Y. h: V6 d( @. P
fractionated cells. In the
$ ^" K1 a3 S0 S9 H9 dEYFP–3 M/ M+ R, r! V! y5 z( W7 u
fraction no changes were observed in the mesodermal
; V5 T5 b7 l: n, M& F3 Hpopulations at E7.75 (supplementary material Fig. S3C,D) and, H6 P7 a+ Q  d; E% B0 r! b" B) k
E8.0 (supplementary material Fig. S3G,H). Analysis of the( W, P0 B5 v  k3 E% S
whole population (the sum of EYFP–0 X" f$ {% i7 m. ]/ |  ?- [" q* K
and EYFP+ gates) showed
) w+ Z6 V* i* n5 o6 V& v4 h& [9 Fno change in cardiac or paraxial populations at E7.75
5 {3 M. a' _; J(supplementary material Fig. S3A,B); but at E8.0, we observed; B) c7 D$ \! J6 H" W
a small, but reproducible, increase in the cardiac mesoderm
, n. k+ ]1 O5 Q6 t+ L(Flk1+/Pdgfra+) (supplementary material Fig. S3E,F). We predict
5 s6 X* A' J2 o- M) e# G) Z, d: M; ^1 jthat the increase in cardiac mesoderm in the whole embryo is! n5 J2 c6 i% T6 d9 Y9 p+ G% F7 f
small because the EYFP+ population is a minor fraction of the/ H  r4 N. O9 K# M4 ]9 o
entire embryo.% ?. B$ @. h5 {% E* d" L
Collectively, our results support the model that, in the Er71
3 \. @9 F# }3 j% }% r$ Jmutant background, EYFP+ cells differentiate to the cardiac
; b5 k% o0 L2 q; Smesoderm lineage and contribute to the increase in cardiac2 x/ J6 _: Q& |; M, v
mesoderm (Flk1+/Pdgfra+) markers, rather than cardiomyocytes or( r( n) N5 w7 C+ [5 C1 ]
cardiac progenitors ectopically expressing EYFP.% R9 P& _% }. z3 ~- u7 T8 S
4805 RESEARCH ARTICLE ER71 governs progenitor fates
/ e; _1 g- t5 K7 A; SFig. 2. The ER71 reporter is misexpressed in Er71 mutant embryos. (A-H)EYFP expression in Er71 wild type (A,C,E,G) and mutant (B,D,F,H)
0 W0 m( c" d$ {5 jmouse embryos at E7.75 (A,B,E,F) and E8.0 (C,D,G,H). Asterisks indicate the cardiac crescent (A,B) or forming linear heart tube (C,D). Arrowheads  A7 Y9 W5 b7 k; V2 R
indicate the bilateral dorsal aortae (C,D) or its progenitors (A,B). Arrows point to regions in which EYFP is misexpressed in the mutant (A-D).9 c: B" J8 n" i- N% m
Representative FACS profiles of individual embryos (E-H) show the percentage of EYFP positive cells per embryo. Scale bars: 200m. (I)The
4 I& d" a7 A' _! Hpercentage of EYFP+ cells for all experiments. (J)The average number of EYFP+ cells sorted per embryo. WT, wild type; HET, Er71 heterozygote; MT,
) {. z, K+ `/ m; Z" `# S9 z; H- k! V6 `homozygous Er71 mutant. ***, P<0.001. Error bars indicate s.e.m.
: z, D) Z9 E: BDEVELOPMENT4806; O" F( M0 `! J! }: @
Cardiac and skeletal muscle genes are
+ U* Y3 L% r, I8 Y! C: Rupregulated in ER71-EYFP+ cells in Er71 mutant2 q0 U$ `* A- _( q% y" G" m
embryos
& y& ?, m; I$ C7 H, `; D, JTo further examine whether the EYFP+ cells in the absence of" _) U! @4 z3 G' @" A
ER71 were redirected to other mesodermal lineages, we performed
9 y% k  \# X4 Ra transcriptome analysis. We used an Affymetrix microarray: y8 o7 X0 t; x, J# ?1 o- M
platform and examined the EYFP-positive and EYFP-negative+ z( I8 K7 E" c' V+ @9 k
cells from wild-type and Er71 mutant littermate embryos. Genes
+ ~( F$ T4 e! r) Xthat were significantly dysregulated were filtered based on the false+ u* n0 f4 ?  e6 _* ?" H; e
discovery rate (FDR<0.01 for EYFP+ versus EYFP–
& S+ Z- W$ d( {6 h8 C" k: K; FDR<0.35 for  E8 l3 J4 \) `/ `7 ^0 O4 `- P
wild type versus mutant; FDR<0.01 for the interaction between! H* F) y9 _  G, g6 N8 Y
these two variables). Clustering analysis was carried out6 F4 \+ N  B5 H: c5 x' z+ V* v
subsequently (Fig. 4A). Interestingly, there were no transcripts that; G* `' Z4 v1 N& ]+ ]( d
showed differential expression between EYFP–/ i$ `4 c  _0 {- u+ ?$ r( s2 c- `8 t( U  B
populations in the
8 y( B* {$ ~, u6 M' v* S% H+ }- X. kEr71 wild-type and mutant backgrounds. Also, the cluster analysis3 Z9 F4 e1 T! h2 I/ d
was unable to resolve differences between the EYFP–2 y" a' t% b( O
populations
% [9 S) n( L/ \3 v% {0 xRESEARCH ARTICLE Development 138 (21)' Z4 ~8 b0 H5 c6 J4 r8 I! ]2 V
Fig. 3. ER71-EYFP+ cells in Er71 mutant mouse embryos lack markers of hematopoietic progenitors in exchange for those of other
3 J: \# [% r/ @; _" Jmesodermal lineages. (A)Using fluorophore-conjugated antibodies and FACS analysis, we observed an enrichment of Pdgfra+ cells in ER71-EYFP+
4 I% H/ I8 ~" G# P2 L6 @mutant cells at E7.75 and E8.0. (B,C)Summary of multiple experiments comparing individual fluorophores Flk1 and Pdgfra (B), and combinations of# z$ G0 v+ z0 e, x4 P  N( q
Flk1 and Pdgfra (C). (D,F)Hematopoietic progenitor cell surface markers are not expressed in the embryo proper at E7.75, but there is a significant
+ w# S4 C+ X# c+ L: H7 R& Treduction in CD41 (D) and CD34 (F) at E8.0. (E)Summary of multiple experiments comparing hemogenic and endothelial markers CD41 and CD34.. V: g% D" Y. n& Z% R! ?
**, P<0.01; *, P<0.05. Error bars indicate s.e.m. LPM, lateral plate mesoderm; CM, cardiac mesoderm; PM, paraxial mesoderm.
" V6 Q% W7 c$ dDEVELOPMENT(Fig. 4A). These transcriptome results for the EYFP–
4 ]' m& _+ H, `4 {8 a; v3 jcells support
( ]4 v7 _1 x2 p3 |  \& ~- f- `: jthe notion that EYFP is not being expressed ectopically.
0 l7 f2 ?) R  C4 s2 c3 p1 T0 R3 T1 pFurthermore, this indicated that there were no significant non-cell-
: B" \1 A+ s! [" c: Bautonomous effects on gene expression resulting from the lack of
9 G# _+ D- f+ \. Z, W7 i% M5 @5 zER71 at this time point./ i+ w3 t5 h, c3 r
Within the EYFP+ populations, the Er71 mutant and wild-type
6 R/ [* m+ H$ I+ B7 m; Q5 s" g) \% Zcells were significantly different (Fig. 4A). A large number of8 |' Q; Z) D+ F: p& G3 F9 q
hematopoietic and endothelial transcripts were decreased in, [$ x, E2 I  o! p, s
expression between  Er71 wild-type EYFP+ and  Er71 mutant
" a3 X. q( Z2 R+ K; x# CEYFP+ cells (Fig. 4C). Importantly, ER71 expression was restricted8 f) z/ N; K, ^. Z* z7 G* [" v& N
to the EYFP+ cells in the wild-type background (Fig. 4C, arrow),7 T; j7 j5 `5 a( r& @/ V9 |
confirming that the  Er71-EYFP transgenic model reflects& `2 c3 K' w: w  }) v/ Y3 p- y
endogenous ER71 expression. Other transcripts that were! a4 T4 i( G$ _# u2 [
downregulated in the mutant EYFP+ cells compared with the Er71
2 A$ S$ h: ]4 D4 Hwild-type EYFP+ cells included endothelial and hematopoietic2 @* t! S7 j& n* r1 V
transcripts such as Hbb-y, Fli1, Erg, Tal1, Cldn5, Cd93, Sox18,
6 V5 [, h, s" }6 R5 l; U8 \Cdh5, Sox7, Mmrn1, Eng and Nos3 (Fig. 4C). These data indicated
; F" J, b4 `0 q9 z. A3 z1 Zthat the EYFP reporter-positive cells contributed to the endothelial) [9 m% T$ d0 d# w( m& D' C
and hematopoietic lineages and did not express markers of those( F# i; ]# O6 u6 v
lineages in the absence of ER71, consistent with the previously, E. z6 y) N0 `. J6 F; {
described phenotypes (Ferdous et al., 2009; Lee et al., 2008).
( w; ~% Y8 R& q$ uTranscripts that were significantly upregulated in the Er71 mutant! d$ J. k  z% Y
EYFP+ cells compared with the Er71 wild-type EYFP+ cells were' }# f- i+ f% X
associated with muscle lineages (Fig. 4B). These transcripts
, U. S! ]; \" }+ O6 Eincluded Smarcd3, Myl3,  Irx4, Tnni1, Myl2 and Tbx5 (cardiac-( C  H0 j* j7 `% `( b/ U
restricted transcripts); Acta1, Myl1, Svep1, Dpf3 and Cdo1 (skeletal  _: o/ e7 P1 V0 R8 @
muscle-expressed transcripts); and  Acta2 and  Myl9 (vascular& F' V: ]* `) y2 z" O) p, B
smooth muscle-specific transcripts). These results suggested that
$ d2 w/ B  {5 [6 [1 hthe EYFP+ cells gave rise to other mesodermal lineages in the0 ?- Q0 j- M4 z/ x
absence of ER71.
9 t7 V1 k7 V: [# I# _) Q/ `4 yIn order to determine whether the cardiac lineage was broadly
& Y. |# I( t% V  W. [$ a1 ?" gaffected, we analyzed transcripts from the cardiac development1 c0 o0 ^* [' l1 Q5 h
gene list in gene ontology (GO) terms and performed a hierarchical* E) e: X$ C% {, U/ E4 \4 e
clustering analysis. Similar to the results obtained from whole-
" ?) P, J$ E# Hgenome analysis, wild-type EYFP+ cells segregated from the- d8 P, c( S7 \% q- f- V; m) p
mutant EYFP+ cells (and all EYFP–" @3 c) O+ d* p2 `9 x6 R3 t
cells) (supplementary material
; ^. a- Q1 i# e- ~  d5 B' L2 tFig. S4A). This result demonstrated that the difference between  X& o; W$ j2 Z/ q
these two populations can also be detected based only on cardiac& t6 K1 f; n) v8 |2 p3 j
development criteria. Some transcripts were decreased in EYFP+
% h5 P; Q- P: L! g6 ~% DEr71 mutant populations compared with EYFP+ wild-type cells,4 m) A  x  r  l& K
including a number of transcripts that are important for endocardial
' e/ e3 L* l# |6 W& @development (including  Eng,  Hhex,  Sox18,  Nfatc1,  Sox17); I0 H% b% x! Z- ~0 {( `& M
(supplementary material Fig. S4B). A number of transcripts were
% |  ~! p9 O7 H  lincreased in expression in the EYFP+ Er71 mutant population
7 t' w) |1 N, F+ Z* ]0 `" ncompared with the other three groups (EYFP+ wild-type and both) i, n  q/ |& s% X* A* ?- U
EYFP–
  l$ B  u5 O* q) d- e* c5 D- \populations), including a number of cardiac transcription% m2 }' v3 y2 T3 J# v2 C2 D
factors (Myocd, Nkx2-5, Irx4, Isl1, Gata6, Tbx20, Tbx5, Gata4,
7 l$ L- z) u: L# GSmyd1 and Srf) and structure-function transcripts (Myl2, Myh7,7 C2 p/ O/ e: o2 T3 y) Z
Myl3, Tnnc1, Tnnt2, Tnni3) (supplementary material Fig. S4C). We  t% p* S6 A: R0 a5 ~5 j9 R) h
validated changes in selected transcripts by qPCR on independent
1 r& O& @1 a8 l/ g; r2 ?9 bsamples and confirmed decreased expression of Er71, Tal1 and  g1 r$ n7 t* @- r1 }! {$ ^
Cdh5 and the overexpression of cardiac transcripts including Nkx2-
& ^/ {6 {0 T$ W4 c6 r! W7 n5, Gata4 and Tbx5 in Er71 mutant EYFP+ cells (Fig. 5).8 {9 J5 g; ?6 `  Y0 _
In summary, our transcriptome analysis indicated that cardiac
% R8 s' X- a0 |& v' tgenes are over-represented in Er71 mutant EYFP+ cells, whereas) [. P4 S( k& n5 ^5 G* F0 a
endothelial, endocardial and hematopoietic genes are under-7 G, W1 P. K  b% q$ J" G9 d
represented.
7 f; Y$ j+ ]( B" Y4 ]* lA novel Er71-Cre transgene marks endothelial and) T" x8 {% D2 U8 z5 z5 {+ w
hematopoietic lineages
. |  \5 H# u9 XIn order to determine whether ER71-expressing cells give rise to
# H( R) F# A4 R& z+ korgans or programs other than the endothelial and hematopoietic8 R0 `# ~2 ^" ^  c% ]
lineages, we generated an Er71-Cre transgenic mouse model (Fig.
+ a3 ]0 H# T4 @; C9 J4 P5 Q' p6A). We obtained a total of six founder lines, with embryos that
4 e1 U) q0 s. t3 ]$ r, a. [showed similar expression patterns after breeding with the Rosa-8 ]9 ~% ?8 q% `$ G8 g
4807 RESEARCH ARTICLE ER71 governs progenitor fates
8 r6 {" k: R" S, IFig. 4. Transcriptome analysis reveals that hemato-endothelial
- A" N+ {0 U0 N$ H- @and cardiac lineages are dysregulated in the Er71 mutant
# A) |6 O# \) R0 _- Rembryo. Transcriptome analysis was performed on EYFP+ and EYFP–8 Y. j$ R) \1 B* `
cells sorted from wild-type and Er71 mutant littermate mouse embryos.
2 q4 {% i% p% O% P(A)Clustering analysis shows that wild-type and mutant EYFP–+ \" X+ d; A  g
cells are
- T# [+ f( k$ n- s; q) tindistinguishable, whereas EYFP+ cells from wild-type and mutant" p6 e8 p8 o. \% g
embryos show distinct gene expression profiles. (B)Transcripts
3 L8 u& F5 S  x0 @7 F% q5 R( [upregulated in the EYFP+ mutant progenitors include cardiac and3 [. F; l& A& n" B) y
skeletal muscle genes. (C)Downregulated transcripts in the Er71
1 G6 ]7 U3 K# g, M* h0 Nmutant background include hemato-endothelial transcripts, including3 m$ B, D# V% ?4 t- r) l9 X6 [
Er71 (Etv2) (arrow)./ B0 o, H% F# s/ [
DEVELOPMENT4808$ O! }3 s9 e9 H/ o7 w
lacZ reporter mice (supplementary material Fig. S5). Two
$ r8 U9 ~1 U  Z, I2 f; w! btransgenic lines were crossed to the Rosa-EYFP reporter mice and+ {( `5 [! O! r
used for immunohistochemical and FACS analyses. Our results# d* J& Z! q& \
revealed that E11.5 embryos were marked by Rosa-EYFP or Rosa-- S% ^6 r* M+ |) l" \6 Q/ _
lacZ in the endocardium, cardiac cushions, vasculature,) m, h" M2 _$ Y4 H$ ~6 Z1 K
mesenchyme and the fetal liver, which is the stage-appropriate site5 `' C+ v6 Q6 D( `+ R
of hematopoiesis (Fig. 6B; supplementary material Fig. S5G,H;
7 X  e4 a; N) e+ Sdata not shown). Hearts of P3 neonates were marked by Rosa-% V: u, B. U8 B) C
EYFP in the vascular structures (Fig. 6C). Co-staining for EYFP/ {) W' H7 ?' ?4 |2 y/ q) O
and desmin, an early muscle-specific structural protein, showed
' Y( B7 |7 ^5 S4 [! gthat the Rosa-EYFP reporter did not overlap with desmin staining0 N2 }% ?5 V; t0 B
in the heart at either time point (Fig. 6B,C). FACS analysis of4 B& s. r/ p, _/ R8 V6 y: ?
whole E11.5 embryos showed that 7-8% of cells in the E11.5
7 M8 ~4 s, O9 F4 q; `embryo were derived from ER71-expressing cells (Fig. 6D,E). Of
# s$ s: i3 F$ N+ t  `* j: O+ ]' v2 Vthese EYFP+ cells, ~12% were endothelial (CD45–
: Z. l) p! Y, g2 W2 P# N2 xCD41–, r  }- v& {) `$ }
Tie2+;
! }* R  s: a- u; x+ J" L) t3 mFig. 6F), 23% were non-erythroid hematopoietic cells (CD45+, also
$ Z9 v& \* s% M* w0 yRESEARCH ARTICLE Development 138 (21)6 U. a9 n5 T6 `* F
Fig. 5. Representative transcripts from the cardiac program are overexpressed in the Er71 mutant. (A-F)qPCR analysis was performed on' ]- b. _2 b, {( A+ n- v0 T
RNA isolated from EYFP+ cells in the wild-type (embryos 1 and 2) and mutant (embryos 3 and 4) backgrounds. We observed the loss of Er71 (A),, s/ h3 _, V; [) @7 l
Cdh5 (B) and Scl (C) expression and an increase in the expression of representative cardiac program transcripts including Nkx2-5 (D), Tbx5 (E), and
3 m6 ^' i+ N; nGata4 (F). Error bars indicate s.e.m.
0 j, J# V" b% Q. Y9 t$ F: X7 @- mFig. 6. Genetic fate-mapping studies indicate that ER71-expressing cells give rise to the endothelial and hematopoietic lineages.0 }3 x! k3 z, B6 u
(A)The transgenic Er71-Cre mouse model used for these studies. (B,C)Immunohistochemistry for GFP (green) and desmin (red) and DAPI staining
! N' x& }% S2 W8 C! e(blue) in E11.5 (B) and P3 (C) heart. a, atria; bw, body wall; cu, cardiac cushion; fl, fetal liver; v, ventricle. (D)A representative FACS profile showing
) |1 O+ O* {7 N9 ?0 wEYFP+ versus side scatter width (SSW). (E)ercentage of Rosa-EYFP+ cells from all experiments (n9). (F-H)EYFP-positive cells were gated and
1 I4 E8 _" v9 I4 @8 `' R6 K, Sanalyzed for lineage contribution. Representative FACS profiles are shown for (F) endothelial lineage (CD41–% ^% U9 D# N; X/ \
CD45–' S5 m9 k) d$ }! ]; Z9 x3 i+ {
Tie2+) cells and (G) CD41+
7 L+ O6 o, ]7 d) e3 MCD45+, (H) CD45+ Ter119–
  F' }- m8 d8 \! ^and Ter119+ CD45–
) c; ^" [4 Y1 I8 Khematopoietic lineage cells. (I)ercentage of Rosa-EYFP+ cells of each lineage from all experiments
; v% ]$ Q% F1 ?5 @# m/ z5 l(n9). Error bars indicate s.e.m. DEVELOPMENTknown as Ptprc; Fig. 6H), and 13% were erythroid (Ter119+; also4 N+ W0 o/ |" S0 p' ]
known as Ly76; Fig. 6H). Interestingly, the EYFP+ population
. D. Z' N2 X# b3 H6 _% zsegregated into two populations of varying EYFP expression (Fig.& f7 U* M5 t$ h6 c; r
6D). Ter119 primarily marked the EYFP-low population, whereas) ]( i% b$ m# ~3 j% L
endothelial and other hematopoietic markers primarily marked the
5 Z1 }: H1 v/ ?7 \. x3 NEYFP-high population (data not shown). This suggests that the9 g3 U/ b; _) j; V2 B
Rosa reporters are expressed weakly in erythroid cells and might
  n: a3 w; G* r. B2 Ltherefore inefficiently mark this population.
! Z9 [7 M. L; L" U0 cER71-EYFP-expressing cells give rise to
( @+ w) f6 W* P3 t! lmyocardium in the Er71 mutant4 w; s; |* N, I
To determine whether ER71 reporter-positive cells could produce
+ g' u, \' j. m9 D) p9 u5 @alternative lineages in the Er71 mutant, we crossed the Er71-Cre, ~/ Z/ _/ u/ x% n5 k4 I
and  Rosa-EYFP alleles into the  Er71 mutant background. As7 ~# V: Y' N: N4 j8 ]
observed with the ER71-EYFP reporter, Er71 mutants carrying the( v9 m0 [/ s* o' o  O0 {7 m
Er71-Cre and  Rosa-EYFP alleles displayed altered EYFP. a" B& E) U- @1 }% F# L
expression patterns. Compared with the Er71 wild-type embryos at
6 x, ~# n* `# ~/ [% eE8.0, in which Rosa-EYFP is expressed in the yolk sac, vessels and0 `1 ]; c1 i% {$ `* t; D
heart tube (Fig. 7A), the Er71 mutant embryos had robust EYFP. M7 C0 F' _$ a3 [
expression localized in the allantois, posterior mesoderm and
" S% y% G) s5 g( r! ^9 h* iparaxial mesoderm (Fig. 7F). We speculate that the increased. N8 `5 w9 U4 B. f9 q, T* Y% B
expression in the allantois and the posterior mesoderm is due to the1 u! E, Z* ]9 w( ^9 R* r% Z
progenitor cells differentiating to alternative mesodermal lineages,
1 e6 t6 N7 C% a1 U& Q- V4 W; kperturbed migration patterns, or a combination of the two. Embryos
0 Z5 h# P5 e: bwere analyzed using immunohistochemical techniques for co-
  T! t6 Y9 v% a9 G; Mexpression of EYFP and Nkx2-5, a cardiac transcription factor,# P- L; L7 N8 U9 A: W2 r, B) c
EYFP and desmin, or EYFP and troponin T, a cardiac sarcomeric; X/ |3 r# j$ m+ k6 v5 G0 D  m
protein. In wild-type hearts at E8.0, EYFP was expressed in the) \5 a9 X5 o; c
endocardium, the major vessels such as the dorsal aortae and in$ k' {7 d2 [* b- u' ^& P
hematopoietic cells within the heart (Fig. 7B-E). There was no
' W% x# L6 ]+ m; B2 ], Z" Poverlap of EYFP expression with Nkx2-5, desmin or troponin T.% @8 ]0 ^. w. c- v! I1 G& }7 M9 g3 f
In the Er71 mutant embryo, the vessels and endocardium were
# g& X' _# _( o/ X2 xabsent. However, EYFP expression persisted in the heart. In the
- A# F; O- s1 T) c3 o: oheart of the Er71 mutant embryo, all EYFP-expressing cells had an
5 Z) P# }( W. m  D6 i" W) tNkx2-5-positive nucleus (Fig. 7G,H). Some of the EYFP-0 e) k$ `7 k( X1 W7 e
expressing cells were also positive for the structural proteins
, \3 G/ k+ X5 d3 ~  R5 U% ^# kdesmin and troponin T (Fig. 7I,J, arrows). These results support the
( o9 T3 Y8 @- Y- j) f6 d: `notion that the EYFP+ cells are capable of differentiating to the
0 n# X5 n$ I# c5 x2 z# Z/ s0 hmyocardial lineage in the absence of ER71. It is likely that
: C3 `  Y; G+ `progenitor cell populations are also capable of differentiating$ Z# J& E  F2 O' Q4 p& H& u
toward other lineages depending on the context of the spatial and: S4 G1 L6 O6 J3 n0 u
temporal cues that they are exposed to during embryogenesis.7 D, ]1 g- D9 I1 H9 w( Q8 b
However, the heart is one of the few organs present at E8.0 and8 D: }1 @9 d( s* G/ ?* u* i+ Y) l
Er71 mutant embryos are nonviable by E9.5. Therefore, the: r( T9 |5 C9 s& Z# R
lethality of the  Er71 mutant limits our ability to evaluate the
  F) _3 |/ e# z- F* c# Y5 @% Xcontribution of EYFP+ progenitors to other lineages that develop7 B# g: _# B( r( S
later during embryogenesis.% u4 [  c, s) W5 [$ e
ER71 overexpression suppresses development of
$ h1 i$ q" w- h3 Jthe cardiac lineage
7 V! Q( b  _3 M- S! PTo complement our analysis of the  Er71 mutant embryo, we( A, W6 g1 {# y' Z3 `+ r
overexpressed ER71 using a doxycycline-inducible embryonic$ u) X4 w: H6 F6 k' q
stem cell (ES)/EB system. An ES cell line in which expression of. k4 j4 ?: v( L# S( F
ER71 can be induced by doxycycline treatment was generated by
3 {! d/ @" L3 Z) u/ Ba cassette exchange method (Iacovino et al., 2009). ES cells were
- d& _- n0 t6 W1 X% h5 v! K% Z% {! Finduced to form EBs in differentiation media and cultured for 10% o2 t- U' F  N3 k0 U! U" ]# H
days with or without 0.5 mg/ml doxycycline from day 3. In the
0 f1 n- S2 J) |% C8 N1 JER71-overexpressing EBs, we observed a decrease in the/ d5 g) v2 C+ s2 R) ~
expression of troponin T, which we quantified by comparing the
- T+ X- E- e+ Ipositively stained area with the total area of the EB (Fig. 8A-E).
) K  o: }2 g, z+ [  B: S8 f% yWe also observed a decrease in cardiac gene expression (Nkx2-5,$ U; c1 H7 t  P, L& r' F
Tbx5 and  Gata4), as quantified by qPCR analyses (Fig. 8F).
" G  v& U4 [" Q/ IFinally, we quantitated the ability of the EBs to beat with edge2 t/ Q: H1 i0 y. p/ O6 L" ]3 b4 j
detection. The doxycycline-induced EBs had a dramatic reduction, |6 R6 m. S6 x5 m
in contractility (Fig. 8G) and in percent shortening (Fig. 8H).
4 f6 g; }  g4 r4 U# kCollectively, these results further support the notion that ER71% c0 q9 D" Y; ^$ t7 h' D/ a0 [; ~5 ], W8 @
suppresses the myocardial fate of mesodermal progenitors.: f- i& ~5 d  d/ A6 I
DISCUSSION' O: `5 j6 s/ ^' {+ Q3 W
An array of signaling cascades and networks govern the fate of
$ J: S! x0 k6 S/ G1 Q. q& Hprogenitor cell populations and their contribution to mesodermal# t/ M0 {# `7 I( \* I5 u+ W
lineages during embryogenesis. Recent studies have demonstrated' r/ @' C4 b7 K3 p
4809 RESEARCH ARTICLE ER71 governs progenitor fates7 s. f+ X. Z+ I$ T. V4 d
Fig. 7. Genetic fate-mapping studies in the Er71 mutant show that the affected lineages give rise to myocardium in vivo. (A,F)Whole-& l7 R' ^! A# ?; N# [3 e( m# Q
mount images of Rosa-EYFP expression in Er71 wild-type (A) and mutant (F) mouse embryos. The red line indicates the plane of sectioning for the
( \3 G6 i1 X, b, \; L! l' z3 `- _corresponding panels. (B,C,G,H) Immunohistochemical analysis of EYFP and Nkx2-5 shown at low (B,G) and high (C,H) magnification. (D,E,I,J)( @: p; [5 K* n/ k- U
Immunohistochemical analysis of EYFP and desmin (D,I) or troponin T (E,J) expression. ys, yolk sac; h, heart; al, allantois; da, dorsal aortae; ec,* I3 x7 B+ g4 M6 X' }' |
endocardium; mc, myocardium. Arrowheads indicate EYFP colocalization with desmin or troponin T. Scale bars: 200m in A,F; 20m in B-E,G-J., ^( Z+ W- J% |' ]! h" Z( L# d
DEVELOPMENT4810
3 o! m9 g( X% jthat various progenitors give rise to multiple mesodermal lineages.
& X% Z+ }2 e' I& K0 zThis broad developmental capacity is evident from the fact that9 B4 ]+ |: H. o8 m) \* R5 P! v
multipotent progenitors have been shown to differentiate to diverse& v3 h* X! n- v* ~
lineages, including hematopoietic, endothelial, cardiomyocyte and9 V- T; @) I1 c
smooth muscle lineages. We have previously demonstrated that
& h& `: W* b8 [4 j: e0 X- o( U; \ER71, a member of the Ets transcription factor family, is essential3 B  }+ D/ T9 T" }0 O
for the development of mesodermal lineages. Er71 mutant embryos
" h+ F2 h1 a0 S9 L1 C$ l2 G: P& Zlack hematopoietic and vascular lineages and are nonviable. Here,5 q  B& A5 Z8 m3 |% X
we have further defined the role of ER71 during mesodermal
/ |: L, a& W2 P. Cpatterning and have made three new discoveries that advance our
$ d# i6 k/ o, a+ A4 k8 Tmechanistic understanding of mesodermal fate decisions during' R  ^/ F& m+ ~7 d
development.# ]* s- z8 ^2 x3 M. @
First, we have defined the expression pattern of ER71 during8 d$ R! u8 f0 e  h
embryogenesis using a newly generated transgenic reporter
! T' ~' Y! k& ~7 @mouse model. Using immunohistochemical techniques, we
7 U5 E/ J/ d4 W  mdemonstrated that ER71 is largely co-expressed with Tie2 in5 j$ N1 T& K% D1 F
endothelial and hematopoietic progenitors. In the absence of+ e9 o9 S. |4 W
ER71, we observed that these progenitors are expanded in
& M; g" _  K5 d4 g7 Hnumber but do not represent the hematopoietic and endothelial1 Q9 x$ E' a: i' i
lineages; rather, they are redirected to other mesodermal1 ]( V. p/ C6 }$ i
lineages, including the cardiac lineage. These data also show that: b( S1 W- ~& l. x
ER71 is not required for the initiation or maintenance of its own# L$ p) Y3 D. U; u4 I' s
expression. In the absence of ER71, this increase in the number
2 h1 A; ]$ {! q7 S, E' e8 mof progenitors (EYFP+ cells) might represent a delay in cell, `* [8 L# M) e" A3 H5 e
cycle withdrawal due to the lack of distinct mesodermal lineages" T# o; W! c! y
(i.e. hematopoietic and endothelial lineages) or, alternatively,
8 L- A. T. ?9 sdecreased programmed cell death involving these progenitors.2 N% l9 o3 ?; ~
We did not observe an increase in apoptosis in the Er71 mutant
( _) M2 ^8 M7 \2 m: Jembryo compared with its wild-type littermate control (Ferdous
7 ~; B$ z! y8 Set al., 2009). Thus, we hypothesize that the progenitor cell4 U, F+ q& M% d/ K
expansion in the absence of ER71 is a result of the lack of
" B- g6 f! i+ b$ Xcellular differentiation to hemato-endothelial lineages.
9 r7 V3 G' S# ]5 n3 t3 VOur second discovery defined the fate of the ER71 progenitors
) `5 R* G/ f. t& U4 Din the presence and absence of ER71. Using genetic fate-mapping
; F0 j/ o3 y1 Q0 h' Lstrategies, FACS and whole-genome analysis, we demonstrated that0 M/ C4 q: h$ ?
ER71 progenitors give rise to hematopoietic, endothelial and
/ S/ s; p' n8 S9 W6 Hmesenchymal lineages. In the  Er71 mutant background, these+ _# o" `. A) Z, L1 |+ j
progenitors (EYFP+ cells) produced other mesodermal lineages,
' C: j) Y1 @1 @$ C8 e/ Lincluding the cardiomyocyte lineage (supplementary material Fig.
+ x( x7 A/ g, r3 B8 x7 v  AS6). Moreover, our FACS and transcriptome data supported the
" r# {$ V% S5 X( e" ~. y$ e: @2 O; U; jnotion that paraxial mesodermal programs (transcripts enriched in, _9 ]% t: F( t+ t, P' c- V% z
the skeletal muscle lineage) were increased in the Er71 mutant
. C7 y  y0 x" m+ W0 n8 s" Mprogenitors. Accumulating evidence suggests that the cardiac and- O0 [" L1 `9 p/ {
hematopoietic lineages develop from a common progenitor and that- d5 r1 y* M6 Z' @1 U# G
the specification of these lineages is inversely regulated. We
0 B' ?; V/ z. F) C' I! z' G8 Krecently demonstrated that Nkx2-5 has a dual transcriptional! p0 [9 e3 B  L  o
regulatory role during embryogenesis as it represses Gata1-; I# x) F8 |* T
mediated hematopoiesis and promotes cardiogenesis of the# r& u: N) k" S  P6 y& m: j* M
multipotent mesodermal progenitors (Caprioli et al., 2011). The
# M( _1 |7 l8 D% \) S% Kresults of the present study further support the plasticity of the# b$ |- u9 [8 ?3 R/ F- H. j
ER71 progenitors and their capacity to respond to cues and" E; K$ y5 \+ A* N& ]6 e! M
contribute to other mesodermal lineages.
6 D0 E$ c, a" o/ ~; l& _/ JThe origin of endocardium relative to the myocardium has
% R# K' X# ]! k) R* Jbeen controversial (Harris and Black, 2010). Studies in zebrafish$ v9 h  \5 V$ b% y' q1 p5 d
and chick suggest that endocardial and myocardial lineages are+ u' e* g. M6 e  N. u
distinct from the point of gastrulation, and there are no
. r3 X( Q& J+ X- a, x9 omultipotent progenitors (Cohen-Gould and Mikawa, 1996; Wei6 [3 v7 p; Z4 y6 W3 w
and Mikawa, 2000). By contrast, lineage-tracing studies in
( b" t7 \+ S6 W8 y& |mouse embryos and ES cells suggest that endocardial
& V; t2 k2 }' _progenitors are specified as multipotent progenitors in the4 e) @$ A* z" h2 N: L5 J
cardiac crescent and cell fate is later specified to either
: ?3 v5 q/ a- S: G% `3 {1 l( Gendocardial, myocardial or vascular smooth muscle fates/ n: J# ^$ s/ p* U' D3 @( F9 o
(Kattman et al., 2006; Misfeldt et al., 2009). In our novel ER71-
* D1 v7 \  M, c! V- q/ _+ Q5 iEYFP reporter mice, we observed weak co-expression of Nkx2-0 |9 l0 s5 J$ N) L$ k
5 protein and EYFP in the cardiac crescent at E7.75. However,
2 N( R" _$ E/ b; `lineage-tracing experiments showed that cells that expressed7 h; d: g+ a9 \- B& |
ER71 during any point in their development did not become1 O. {, V, y# a" @- |  E" L
cardiomyocytes. By contrast, Nkx2-5-Cre lineage-tracing9 c5 W  D* C5 @' E
experiments show that at least some of the endocardial lineage
6 l  L/ C+ r' b$ B$ yderives from cells that expressed Nkx2-5 (Stanley et al., 2002).
& L: H- |3 Q$ l8 u- M: t, fTaken together, these observations favor a model in which! T' {% t4 P& ?$ i. b* `+ E
common progenitors of endocardial and myocardial lineages are0 K( h$ P0 Q; y1 ]
specified as Nkx2-5+ cells in the cardiac crescent, but those that" s! u% D% n2 t0 X
RESEARCH ARTICLE Development 138 (21)4 z+ O% P) s! \4 \7 s
Fig. 8. Overexpression of ER71 in differentiating EBs inhibits. D) X$ `; g* N" {& z0 T7 w' m& b
cardiac development. (A-D)Sections of representative EBs either! s% `# v& w! M0 j' ^7 O9 l8 B
untreated (A,C) or induced to overexpress ER71 (B,D) stained with( n# `. A: `* G5 ~3 V! j# Y# r
Hematoxylin and Eosin (C,D) or anti-TnT (A,B). (E)Quantitative analysis of& a' s& w9 v" l
the troponin T-positive area in 33 induced (Dox) and 42 untreated
: M  ^, r2 s  ]) ?9 Y8 fsections. (F)qRT-PCR confirms that representative cardiac program1 u- M+ Z/ S# a
transcripts (Nkx2-5, Tbx5, Gata4) are downregulated in ER71-
# n  A9 `( U  Roverexpressing EBs. (G,H)Extent of contraction and relaxation after 2
* l1 O  [* X0 Gseconds of stimulation (G) and percent shortening (H) are reduced in
3 o: x/ \& C  `* x1 ^ER71-overexpressing EBs. ****, P<0.001; *, P<0.05. Error bars indicate- p6 a" ^9 L* U4 H$ |' I- q
s.e.m./ i4 Z  `, G2 g1 f( i9 k/ M. F
DEVELOPMENTwill become endocardium will downregulate myocardial0 C% }" b: U( q9 k
potential, including the expression of Nkx2-5. Once ER71 is
# p" v% G( ^% Wexpressed, the fate is restricted to endocardium, and not3 f( f  O; m1 w( ~9 C* q
myocardial lineages. Future studies are warranted to decipher the
8 r+ r3 w( |* pmechanism that governs the specification of endocardial cells
% }+ E4 H: @7 F, Lwithin the cardiac progenitor pool.0 J; Y, A$ @& B+ a- R2 y) q
Our third finding is that ER71 overexpression repressed cardiac9 c! w6 [1 C  C- F# Z2 g  J" u3 q
potential. These results support the notion that ER71, like Nkx2-5,
' u. j/ b  G: U/ ]has reciprocal and overlapping dual roles in the specification of
% N! n+ p6 f" H2 Omesodermal lineages. Our previous studies demonstrated that5 G0 ~6 ?4 A0 J/ y! R) J! h! ?+ a- a
Nkx2-5 overexpression suppressed hematopoiesis, but not the
+ a8 v' [( W# y0 T) Kendothelial program (Caprioli et al., 2011). We further defined that
+ B5 A, p6 z+ INkx2-5 could, in a context-dependent fashion, transcriptionally
# i/ M; B& M' K4 t+ i* aactivate  Er71 and promote endocardial lineage development/ t; Y) d4 M' J
(Ferdous et al., 2009). Collectively, our previous studies and recent
% s3 i1 f# g9 Z" N9 z2 qresults support the notion that distinct transcriptional networks can,
- ^7 m' y9 \" c7 X  Oin a context-dependent fashion (and dependent on the local
* s5 z0 R4 ^: L8 w% M1 ?, eenvironment), activate a hematopoietic or endothelial program and. w# U  g7 C8 J. g( U1 S/ N
antagonize the cardiac program. These studies further emphasize
. R. Y7 ]- `  ethe plasticity of progenitors and their contribution to distinct9 o2 p8 Z  A/ K4 Z( |# q) N
lineages.- d* ~, v3 }+ e  X, [; a* t
In summary, our data support a dual role for ER71 in the
2 n, C: P; Q( F, ispecification of the endothelial and hematopoietic lineages and the
& g9 V% `8 \6 O! S3 [3 L! e6 a) \suppression of other lineages (i.e. myocardial and paraxial
3 i+ e; k/ ~/ L4 Lmesodermal cell fates) (supplementary material Fig. S6). Our. ?. h; u* ]1 D1 U5 Q. _- n- F
studies further support the notion of multipotent mesodermal
4 m2 ^( `8 B; fprogenitors that are dependent on transcriptional cascades and other
  H9 z8 r! W% j( }1 wcues to direct them to populate one or more lineages. Moreover,/ x7 R/ R+ `5 |; i; F
our studies reveal that global deletion of a single gene (i.e. Er71)
- _- G# ^. }9 A8 c& ], k/ d6 xaborts one or more lineages and redirects the cells to other lineages$ W" v0 e: i$ c
that would not typically arise from those progenitors. These studies2 l5 E6 R0 B, [  Q3 g! l
further our understanding of the regulatory mechanisms that govern; J* B0 o4 J7 _/ \* k# f) I4 O
mesodermal cell fate decisions and embryogenesis.
1 G4 O0 s5 d* E3 ?( LAcknowledgements8 H2 S$ w  H. o) N. T
We thank Jennifer L. Springsteen and Alicia M. Wallis for assistance with7 b1 {' N3 \2 ?8 Y4 Y7 p6 @
histological analyses and animal care.
5 e5 ?9 c+ D, G) _9 X) D7 C' ZFunding3 `+ o, Y8 @% Q& w5 m" R+ A& s' P; `
Funding support was obtained from the National Institutes of Health [U012 }& P+ X5 E  n
HL100407 and R01 HL085729 to D.J.G.]; and the American Heart Association
1 [) z4 c3 O" o/ Z[Jon Holden DeHaan Foundation 0970499 to D.J.G.]. Deposited in PMC for
! I/ S7 [; Y. w3 ]5 I+ T5 _. xrelease after 12 months.0 \& o' u" M/ d" x# ?1 _1 d
Competing interests statement
' ]! T% X" j3 e- d) CThe authors declare no competing financial interests.
- \2 ^/ U% [7 e1 U' L1 Q) rSupplementary material
0 c8 T/ M9 t8 F( M" K; BSupplementary material available online at% V5 g  m1 h' U
http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.070912/-/DC1
: q+ ^: G6 Z2 u4 g# s, W# _References: Q1 a! O' S9 \' d1 h
Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: a$ G# v7 j6 t1 R; p, W" a% [
practical and powerful approach to multiple testing. J. R. Statist. Soc. B 97, 289-
; H- j+ F- {% F: @; v300.
0 x, t* J0 I. Y% X* g, e; }Bondue, A., Tannler, S., Chiapparo, G., Chabab, S., Ramialison, M.,
1 `# c' c) C/ v( |$ GPaulissen, C., Beck, B., Harvey, R. and Blanpain, C. (2011). Defining the% {/ g( c8 l8 b
earliest step of cardiovascular progenitor specification during embryonic stem, D9 P7 u$ U; l2 {! ~
cell differentiation. J. Cell Biol. 192, 751-765.
0 Y5 e  U/ u$ J3 uCaprioli, A., Koyano-Nakagawa, N., Iacovino, M., Shi, X., Ferdous, A.,2 C1 u/ k7 n/ W4 h
Harvey, R. P., Olson, E. N., Kyba, M. and Garry, D. J. (2011). Nkx2-59 A' p. ?+ W9 `% r" M) `
represses Gata1 gene expression and modulates the cellular fate of cardiac4 a0 _2 s3 a" I: a  A4 @
progenitors during embryogenesis. Circulation 123, 1633-1641.
* o& _9 `* B6 ~Carbon, S., Ireland, A., Mungall, C. J., Shu, S., Marshall, B. and Lewis, S.
& t" c+ ~. b5 @! K7 R) E9 c(2009). AmiGO: online access to ontology and annotation data. Bioinformatics
0 C5 d3 Z5 }' e* B; x# d! C, N4 n& l25, 288-289.- I# D; C2 B( l* X) u, i# _
Cohen-Gould, L. and Mikawa, T. (1996). The fate diversity of mesodermal cells5 n) F& e# {, Q$ P1 M  M% s$ Z+ Z
within the heart field during chicken early embryogenesis. Dev. Biol. 177, 265-+ [5 V4 }1 c6 m2 x& W; J- B- K
273.
4 u3 ?/ _- `, @- v9 M5 g( {# B6 ZDavis, L. A. and Zur Nieden, N. I. (2008). Mesodermal fate decisions of a stem! s3 W( N- g3 c$ l! l
cell: the Wnt switch. Cell Mol. Life Sci. 65, 2658-2674.
; I$ C+ B* h2 {& i9 Dde Hoon, M. J., Imoto, S., Nolan, J. and Miyano, S. (2004). Open source
" \/ V5 n% g( i) Rclustering software. Bioinformatics 20, 1453-1454.$ m( {! B0 O; v2 q7 @/ h
De Val, S., Chi, N. C., Meadows, S. M., Minovitsky, S., Anderson, J. P., Harris,
0 |. n) b) U( }2 X+ [3 wI. S., Ehlers, M. L., Agarwal, P., Visel, A., Xu, S. M. et al. (2008).( X, N& t  ~; p6 K' `
Combinatorial regulation of endothelial gene expression by ets and forkhead# s( j0 s& Z5 i7 [
transcription factors. Cell 135, 1053-1064.6 S+ ^6 |7 q0 w" a; t. J" L
Downs, K. M. and Davies, T. (1993). Staging of gastrulating mouse embryos by
2 ~( k! W2 C$ H( zmorphological landmarks in the dissecting microscope. Development 118, 1255-
' l! b3 T7 W" a3 I0 K: b( T% I1266.
$ c0 `* g* q6 F9 f! |" zDumont, D. J., Yamaguchi, T. P., Conlon, R. A., Rossant, J. and Breitman, M.8 k! b* Q, y0 S* ^) |, r9 e
L. (1992). tek, a novel tyrosine kinase gene located on mouse chromosome 4, is
. R, H, v4 \7 G5 L0 yexpressed in endothelial cells and their presumptive precursors. Oncogene 7,
8 C  p5 S- e' b$ `6 i4 Q1471-1480.
- B7 T4 F  W/ \6 e& r- `' eEma, M., Takahashi, S. and Rossant, J. (2006a). Deletion of the selection0 }. M% _# W+ {2 o; x' X3 ~
cassette, but not cis-acting elements, in targeted Flk1-lacZ allele reveals Flk16 y5 D0 G+ h9 \! x" I
expression in multipotent mesodermal progenitors. Blood 107, 111-117.
/ n3 n& `) s& _. ~: H- x% vEma, M., Yokomizo, T., Wakamatsu, A., Terunuma, T., Yamamoto, M. and
- [$ @# Z( B. B% E; n- tTakahashi, S. (2006b). Primitive erythropoiesis from mesodermal precursors
& U7 ?; j7 d) _5 }expressing VE-cadherin, PECAM-1, Tie2, endoglin and CD34 in the mouse6 r9 b+ E; S( H+ l
embryo. Blood 108, 4018-4024.% N% x! u* R+ y3 |
Ferdous, A., Caprioli, A., Iacovino, M., Martin, C. M., Morris, J., Richardson,3 [& W! k' t) D* g4 r" ~/ _- W- X
J. A., Latif, S., Hammer, R. E., Harvey, R. P., Olson, E. N. et al. (2009). Nkx2-
* z- o, q. t! W1 E1 Y2 e4 `6 R1 m5 transactivates the Ets-related protein 71 gene and specifies an endothelial/' {& b- f6 T9 N: q* o
endocardial fate in the developing embryo. Proc. Natl. Acad. Sci. USA 106, , V! G# j+ @" j3 x) U
814-819.) |, h, v/ z* g0 x  C; O  C
Harris, I. S. and Black, B. L. (2010). Development of the endocardium. Pediatr.
4 {! u8 u$ I5 L% s9 t- n# |Cardiol. 31, 391-399.2 ]5 {, c. |( ?3 z, f. E4 g
Iacovino, M., Hernandez, C., Xu, Z., Bajwa, G., Prather, M. and Kyba, M." A) a! U, V, t( |6 r! L
(2009). A conserved role for Hox paralog group 4 in regulation of hematopoietic4 I# E/ N9 \6 l
progenitors. Stem Cells Dev. 18, 783-792.
2 k6 i' X- G; v1 i" C, @, i; mIrizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J.,( ?( ^/ l8 W& L8 H3 t
Scherf, U. and Speed, T. P. (2003). Exploration, normalization and summaries4 ~$ d, X, i# b) {5 h+ N
of high density oligonucleotide array probe level data. Biostatistics 4, 249-264.
& f9 e% Y5 F2 q  {* _# Z) `7 R( x, ^Ivey, K. N., Muth, A., Arnold, J., King, F. W., Yeh, R. F., Fish, J. E., Hsiao, E. C.,5 p9 W7 Q5 P4 N
Schwartz, R. J., Conklin, B. R., Bernstein, H. S. et al. (2008). MicroRNA
$ y: L- ^8 Q0 y5 p* W. Gregulation of cell lineages in mouse and human embryonic stem cells. Cell Stem  s9 @5 X1 i1 N" [3 b
Cell 2, 219-229.
$ u+ K0 ^0 r1 z* n' R7 PKataoka, H., Takakura, N., Nishikawa, S., Tsuchida, K., Kodama, H.,
9 ]# p- X8 s! C& y# R' I5 UKunisada, T., Risau, W., Kita, T. and Nishikawa, S. I. (1997). Expressions of
: [# E: n6 k2 @0 }1 l- l6 i8 bPDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 52 S. e1 Y. u" j: p" _; P$ S4 w
define distinct subsets of nascent mesodermal cells. Dev. Growth Differ. 39, 729-& R) C; w3 |5 T' |' q
740.2 k# K4 j& h( M
Kattman, S. J., Huber, T. L. and Keller, G. M. (2006). Multipotent flk-1+
7 B, k9 J+ U' ?. O. Dcardiovascular progenitor cells give rise to the cardiomyocyte, endothelial and: z4 g1 a- _* L! I6 }# }& G7 E0 ~
vascular smooth muscle lineages. Dev. Cell 11, 723-732.0 D; T0 x3 E1 B
Kaufman, M. H. (1992). The Atlas of Mouse Development. London: Academic) }0 p& O( M& s. J1 g
Press.
0 }" K4 }$ u1 U  u3 W# F) IKennedy, M., Firpo, M., Choi, K., Wall, C., Robertson, S., Kabrun, N. and0 _' r) r  K1 Q  H
Keller, G. (1997). A common precursor for primitive erythropoiesis and
7 P* @) c4 o) C: g5 M0 J0 Z7 Ldefinitive haematopoiesis. Nature 386, 488-493.
/ T0 o, `, i0 U  y$ \2 f) d: Q  JKisanuki, Y. Y., Hammer, R. E., Miyazaki, J., Williams, S. C., Richardson, J. A.
+ v3 w9 F: m* }: _* Y) T, O0 e) x& Kand Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for
- o' m/ |- ?* r4 A; n7 `5 uendothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
' y7 x5 K) _) XLee, D., Park, C., Lee, H., Lugus, J. J., Kim, S. H., Arentson, E., Chung, Y. S.,' q; c8 o8 t) H4 `
Gomez, G., Kyba, M., Lin, S. et al. (2008). ER71 acts downstream of BMP,2 Y- m8 m- y, w  X8 }. ~
Notch and Wnt signaling in blood and vessel progenitor specification. Cell Stem
$ B; D+ i0 f6 z7 XCell 2, 497-507.
- R& R: i, D7 }7 Z/ r6 w5 wLi, W., Ferkowicz, M. J., Johnson, S. A., Shelley, W. C. and Yoder, M. C.. v9 o0 a6 F( ^: G1 X
(2005). Endothelial cells in the early murine yolk sac give rise to CD41-expressing
2 r0 L9 R# ~9 {8 xhematopoietic cells. Stem Cells Dev. 14, 44-54.
4 C! i% G3 z( I4 o) I+ AMisfeldt, A. M., Boyle, S. C., Tompkins, K. L., Bautch, V. L., Labosky, P. A. and
. Z6 c0 n- O1 ?) H& aBaldwin, H. S. (2009). Endocardial cells are a distinct endothelial lineage# q* W6 [) Y4 C$ `5 P/ Y3 n' B
derived from Flk1+ multipotent cardiovascular progenitors. Dev. Biol. 333, 78-% d! i# `2 p/ u+ g# w& V
89.
- D/ {; b. @9 DMoretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y.,/ [& [9 \. J! H
Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S. et al. (2006). Multipotent
: d1 w; m! G  oembryonic isl1+ progenitor cells lead to cardiac, smooth muscle and endothelial
8 @& p% r; |: R  D+ ^" k: Ucell diversification. Cell 127, 1151-1165., s$ l, E- d" x" q1 _
Motoike, T., Markham, D. W., Rossant, J. and Sato, T. N. (2003). Evidence for
& a8 Q3 U5 [; ~3 Cnovel fate of Flk1+ progenitor: contribution to muscle lineage. Genesis 35, 153-5 @$ q# [0 ~6 w+ I5 p. G: u0 Q# R2 `
159.
# A9 O6 N$ j# rOmelyanchuk, N., Orlovskaya, I. A., Schraufstatter, I. U. and Khaldoyanidi,4 `) `7 I: ?1 _; n
S. K. (2009). Key players in the gene networks guiding ESCs toward mesoderm.' @* m  E$ [+ p
J. Stem Cells 4, 147-160.# ]* Q$ P7 Q: X- J
Park, M., Yaich, L. E. and Bodmer, R. (1998). Mesodermal cell fate decisions in0 u- J/ p; g2 w
Drosophila are under the control of the lineage genes numb, Notch and7 ?) V( I4 T' _1 s+ g  T$ e
sanpodo. Mech. Dev. 75, 117-126.
& P: `/ y) }- @) p  E4811 RESEARCH ARTICLE ER71 governs progenitor fates/ ^; @2 L0 O. _  }6 b$ ]1 n% c9 z
DEVELOPMENT48123 R# O2 J- d# b: W* I2 J
Sarb, S., Cimpean, A. M. and Grigoras, D. (2010). Tie2 expression in human4 `+ M. i# Y+ r; j  T: y
embryonic tissues. Rom. J. Morphol. Embryol. 51, 81-84.# G. N" S& p. ]: h+ s
Schlaeger, T. M., Bartunkova, S., Lawitts, J. A., Teichmann, G., Risau, W.,/ B  q: p/ m; q4 X% G/ u
Deutsch, U. and Sato, T. N. (1997). Uniform vascular-endothelial-cell-specific
; g% o; v# W( Q0 \$ h' D; V1 tgene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad.
( X- L1 d: h' \7 L" V! tSci. USA 94, 3058-3063.& {& @+ `+ \. i
Schnurch, H. and Risau, W. (1993). Expression of tie-2, a member of a novel
/ u% z, l# D* Q( cfamily of receptor tyrosine kinases, in the endothelial cell lineage. Development
! R( `3 A8 V3 L1 E- u3 l; q0 x119, 957-968.
, V# V/ ^) \+ `" {Smyth, G. (2005). limma: linear models for microarray data. In Bioinformatics and
# l+ F% p; B# X0 U% [7 @- s% _Computational Biology Solutions Using R and Bioconductor (ed. V. J. C. Robert
3 \: `2 Q8 `! ZGentleman, W. Huber, R. A. Irizarry and S. Dudoit), pp. 397-420. New York:
8 U! w- w. e# G3 rSpringer.4 j% _4 C0 y& E6 L+ o
Stanley, E. G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L. and
8 ~. v- ^5 y4 s9 L5 O: B7 G  YHarvey, R. P. (2002). Efficient Cre-mediated deletion in cardiac progenitor cells
5 F. r: T4 v6 B; c& c- y8 I2 J5 dconferred by a 3UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int. J. Dev.
. W  ~9 U6 a8 W8 ~1 B1 Z+ ^Biol. 46, 431-439.' R' v5 B( R' B8 C; `( _2 p
Takakura, N., Yoshida, H., Ogura, Y., Kataoka, H. and Nishikawa, S. (1997).
. h1 {8 j' x7 ?: I. k# l, p; MPDGFR alpha expression during mouse embryogenesis: immunolocalization
3 D# |" d2 e+ G7 w5 Canalyzed by whole-mount immunohistostaining using the monoclonal anti-! W' R3 U, N* }9 V3 K, e
mouse PDGFR alpha antibody APA5. J. Histochem. Cytochem. 45, 883-893.
/ W$ P& i! ?7 r: F3 kWei, Y. and Mikawa, T. (2000). Fate diversity of primitive streak cells during heart. ^& K( B$ l2 H0 `
field formation in ovo. Dev. Dyn. 219, 505-513.
$ V- u* C! P( t8 P& x* \6 uWu, S. M., Fujiwara, Y., Cibulsky, S. M., Clapham, D. E., Lien, C. L.,
- q' T) ^, ~- R" L6 T9 [Schultheiss, T. M. and Orkin, S. H. (2006). Developmental origin of a# i- W; ^6 Q# C' H
bipotential myocardial and smooth muscle cell precursor in the mammalian
6 _* @( T6 f0 k. ?$ Theart. Cell 127, 1137-1150.
7 \! u0 y- W) g7 LRESEARCH ARTICLE Development 138 (21)
8 `& i; j. E/ E$ T  WDEVELOPMENT
已有 1 人评分包包 收起 理由
细胞海洋 + 5 欢迎参与文献互助

总评分: 包包 + 5   查看全部评分

‹ 上一主题|下一主题 ›
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-11-21 02:32

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.